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i. Abstract 
 
Mouse small intestine is a highly organized tissue with a three dimensional structure 
with finger-like protrusions – villi – surrounded at the base my multiple invaginations – 
crypts of Lieberkühn – making it the body largest interface. Due to the constant 
exposure to harsh conditions, the small intestine has a high cell renewal rate fuelled by  
stem cells present at the bottom of the crypts. In embryos, the structure that will give 
rise to the small intestine is formed around e8.5 to e9.0 and progressively acquires the 
characteristics of the small intestine with villus emerging at e15. At this time, cell 
proliferation is restricted to the intervillus region and will continue to be located there 
until the crypts develop in the postnatal period. 
This work aimed to 1) validate the transcription profile of the ISCs previously obtained 
by performing in-situ hybridization analysis on paraffin sections of mouse embryos 
(e12.5, e13.5, e14.5 and e15.5) and adult small intestine and 2) understand in more 
detail the mechanisms involved in gene regulation by focusing in DNA methylation 
performing MBD-seq analysis. Bisulfite sequencing protocol was optimized for further 
DNA methylation analysis. 
ISH analysis of Hes1, Notch2, Ascl2, Muc4, Dusp1, Cps1, Kcne3, Igfbp5 and Shh was 
indicative that the genetic program leading to the adult small intestine change, as target 
genes were detected to be expressed at different developmental stages. MBD-seq data 
allowed to detect also changes in DNA methylation in the genes Shh, Grb10, Foxa1, Id2, 
Ndufaf3, Nrp, Fz2, Meis1, Mdk, Efbn2, Lgr5, Vdr, Olfm4, Elf3, Ephb3 and Oct4. For 
the majority of the genes, an active transcription was associated with unmethylation of 
the DNA and methylation increased as the genes were inactive. In respect to the genes 
where this relation was not possible to establish, transcription regulation as result of 
other epigenetic markers should be investigated.  
 
 
Key works: Small intestine, villi, crypt, intestinal stem cells, DNA methylation, 
epigenetic markers 
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ii. Resumo 
 
O intestino delgado de ratinho é um tecido extremamente organizado, caracterizado por 
uma estrutura tridimensional. Esta estrutura apresenta protrusões em direcção ao 
lúmen – as vilosidades – rodeados na sua base por várias invaginações – as criptas de 
Lieberkühn. Como consequência desta estrutura, o intestino delgado é a maior 
superfície do corpo e está exposto constantemente a condições extremamente agressivas. 
Por este motivo, este tecido apresenta uma taxa de renovação celular extremamente 
elevada. A renovação do epitélio intestinal é assegurada pelas células estaminais 
presentes no fundo das criptas. A nível embrionário, a estrutura que irá dar origem ao 
intestino delgado forma-se no estadio e8.5 a e9.0, a partir da qual adquire 
progressivamente as características do intestino delgado funcional. As vilosidades 
surgem cerca de e15.0 e a região de proliferação celular restringe-se ao tecido entre as 
vilosidades onde permanecem até à formação das criptas após o nascimento. 
Este trabalho propôs-se a 1) validar o perfil de transcrição das células estaminais 
intestinais que havia sido determinado previamente, recorrendo para o efeito a 
hibridação in-situ de secções de embriões de ratinho (e12.5, e13.5, e14.5 e e15.5) e de 
intestino delgado em parafina, bem como 2) compreender mais detalhadamente os 
mecanismos envolvidos na regulação da transcrição de genes focando-se na metilação 
do ADN através de análise por MBD-seq. O protocolo de sequenciação após tratamento 
com bissulfito de sódio foi optimizado para análises posteriores de metilação do ADN. 
A análise por hibridação in-situ de slides do genes Hes1, Notch2, Ascl2, Muc4, Dusp1, 
Cps1, Kcne3, Igfbp5 e Shh produziu resultados que indicam que o programa genético 
que conduz a um intestino delgado maduro é alterado. Isto é baseado nas alterações 
observadas na expressão dos genes cujos transcritos eram detectados em diferentes 
estadios de desenvolvimento. Relativamente aos dados de MBD-seq, estes permitiram 
detectar alterações na metilação dos genes Shh, Grb10, Foxa1, Id2, Ndufaf3, Nrp, Fz2, 
Meis1, Mdk, Efbn2, Lgr5, Vdr, Olfm4, Elf3, Ephb3 e Oct4. Para a maioria destes genes 
foi possível estabelecer uma relação entre o estado de transcrição e os níveis de 
metilação do ADN que os codifica – nos genes que estavam a ser transcritos a metilação 
do ADN era reduzida ou inexistente enquanto que os níveis de metilação aumentavam 
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consoante os genes estavam inactivos. Relativamente aos genes a respeito dos quais não 
foi possível manter esta relação, seria importante validar a hipótese de que outros 
marcadores epigenéticos possam estar envolvidos na regulação da expressão. 
 
Palavras-chave: Intestino delgado, vilosidades, criptas, células estaminais do intestino, 
metilação do ADN, marcadores epigenéticos  
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continues to elongate and at e14.0 the epithelium changes from a thightly 
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to form (C). Villus start to emerge at e15 (D) becoming evident at e16.5 (E). 
From e17, proliferative cells are restricted to the intravillus region – in green 
(F). Image from Spence et al (2011). 
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Fig 1.6 Schematic representation of the canonical Wnt/b-catenin pathway. In the 
presence of Wnt ligands the ubiquitination of b-catenin is blocked and b-catenin 
translocates into the nucleus. The expression of Wnt dependet genes is induced 
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54 
Fig 4.2 Products of PCR reaction for the amplification of a fragment of Ngn3 on a 1.5% 
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and lane 1 is the probe for Notch2. (Samples run from the highest to the lowest 
molecular weight). 
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Fig 4.5 Ngn3 probe, DIG-labeled, with 5 l of Orange DNA Loading dye in a 1.5% 
agarose gel stained with EtBr. Lane L is the ladder Gene Ruler 1Kb Plus DNA 
and lane 1 is the probe for Notch2. (Samples run from the highest to the lowest 
molecular weight). 
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Fig 4.6 Expression pattern of the gene Ascl2 resulting from RNA-seq (A) and ISH (B to 
F). Data from RNA-seq (A) show the expression pattern between mouse e12.5 
and adult ISC. ISH specific for the gene Ascl2 in fixed sections of mouse 
embryos e12.5 (B), e13.5 (C), e14.5 (D) and e15.5 (E) and adult mouse small 
intestine (F). Note the different structures present in the sections throughout the 
developmental stages, l – lumen, e - endothelium, m – mesenchyme, iv – 
intravillus region, v – villi, c – crypt. Scale bar corresponds to 50m. 
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Fig 4.7 Expression pattern of the gene Btg2 resulting from RNA-seq (A) and ISH (B to 
F). Data from RNA-seq (A) show the expression pattern between mouse e12.5 
and adult ISC. ISH specific for the gene Btg2 in fixed sections of mouse 
embryos e12.5 (B), e13.5 (C), e14.5 (D) and e15.5 (E) and adult mouse small 
intestine (F). Note the different structures present in the sections throughout the 
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intravillus region, v – villi, c – crypt. Scale bar corresponds to 50m. 
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Fig 4.8 Expression pattern of the gene Cps1 resulting from RNA-seq (A) and ISH (B to 
F). Data from RNA-seq (A) show the expression pattern between mouse e12.5 
and adult ISC. ISH specific for the gene Cps1 in fixed sections of mouse 
embryos e12.5 (B), e13.5 (C), e14.5 (D) and e15.5 (E) and adult mouse small 
intestine (F). Note the different structures present in the sections throughout the 
developmental stages, l – lumen, e - endothelium, m – mesenchyme, iv – 
intravillus, v – villi, c – crypt. Scale bar corresponds to 50m. 
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Fig 4.9 Expression pattern of the gene Dusp1 resulting from RNA-seq (A) and ISH (B 
to F). Data from RNA-seq (A) show the expression pattern between mouse 
e12.5 and adult ISC. ISH specific for the gene Dusp1 in fixed sections of mouse 
embryos e12.5 (B), e13.5 (C), e14.5 (D) and e15.5 (E) and adult mouse small 
intestine (F). Note the different structures present in the sections throughout the 
developmental stages, l – lumen, e - endothelium, m – mesenchyme, iv – 
intravillus, v – villi, c – crypt. Scale bar corresponds to 50m to all sections 
except F, where it corresponds to 75m. 
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F). Data from RNA-seq (A) show the expression pattern between mouse e12.5 
and adult ISC. ISH specific for the gene Hes1 in fixed sections of mouse 
embryos e12.5 (B), e13.5 (C), e14.5 (D) and e15.5 (E) and adult mouse small 
intestine (F). Note the different structures present in the sections throughout the 
developmental stages, l – lumen, e - endothelium, m – mesenchyme, iv – 
intravillus, v – villi, c – crypt. Scale bar corresponds to 50m to all sections 
except F, where it corresponds to 75m. 
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Fig 4.11 Expression pattern of the gene Igfbp5 resulting from RNA-seq (A) and ISH (B 
to F). Data from RNA-seq (A) show the expression pattern between mouse 
e12.5 and adult ISC. Note the exon represented with the solid box at the bottom. 
ISH specific for the gene Igfbp5 in fixed sections of mouse embryos e12.5 (B), 
e13.5 (C), e14.5 (D) and e15.5 (E) and adult mouse small intestine (F). Note the 
different structures present in the sections throughout the developmental stages, 
l – lumen, e - endothelium, m – mesenchyme, iv – intravillus, v – villi, c – 
crypt. Scale bar corresponds to 50m to all sections except F, where it 
corresponds to 75m. 
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Fig 4.12 Expression pattern of the gene Kcne3 resulting from RNA-seq (A) and ISH (B 
to F). Data from RNA-seq (A) show the expression pattern between mouse 
e12.5 and adult ISC. Note the exon represented with the solid box at the bottom. 
ISH specific for the gene Kcne3 in fixed sections of mouse embryos e12.5 (B), 
e13.5 (C), e14.5 (D) and e15.5 (E) and adult mouse small intestine (F). Note the 
different structures present in the sections throughout the developmental stages, 
l – lumen, e - endothelium, m – mesenchyme, iv – intravillus, v – villi, c – 
crypt. Scale bar corresponds to 50m to all sections except F, where it 
corresponds to 75m. 
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Fig 4.13 Expression pattern of the gene Muc4 resulting from RNA-seq (A) and ISH (B to 
E). Data from RNA-seq (A) show the expression pattern between mouse e12.5 
and adult ISC. Note the exon represented with the solid box at the bottom. ISH 
specific for the gene Muc4 in fixed sections of mouse embryos e12.5 (B), e14.5 
(C), e15.5 (D) and adult mouse small intestine (E). Note the different structures 
present in the sections throughout the developmental stages, l – lumen, 
e - endothelium, m – mesenchyme, iv – intravillus, v – villi, c – crypt. Scale bar 
corresponds to 50m to all sections except E, where it corresponds to 75m. 
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Fig 4.14 Expression pattern of the gene Notch2 resulting from RNA-seq (A) and ISH (B 
to E). Data from RNA-seq (A) show the expression pattern between mouse 
e12.5 and adult ISC. Note the exon represented with the solid boxes at the 
bottom. ISH specific for the gene Notch2 in fixed sections of mouse embryos 
e13.5 (B), e14.5 (C), e15.5 (D) and adult mouse small intestine (E). Note the 
different structures present in the sections throughout the developmental stages, 
l – lumen, e - endothelium, m – mesenchyme, iv – intravillus, v – villi, c – 
crypt. Scale bar corresponds to 50m to all sections except E, where it 
corresponds to 75m. 
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Fig 4.15 Expression pattern of the gene Shh resulting from RNA-seq (A) and ISH (B to 
E). Data from RNA-seq – number of reads (A) show the expression pattern 
between mouse e12.5 and adult ISC. Note the exon represented with the solid 
box at the bottom. ISH specific for the gene Shh in fixed sections of mouse 
embryos e12.5 (B), e14.5 (C), e15.5 (D) and adult mouse small intestine (E). 
Note the different structures present in the sections throughout the 
developmental stages, l – lumen, e - endothelium, m – mesenchyme, iv – 
intravillus, v – villi, c – crypt. Scale bar corresponds to 50m to all sections 
except E, where it corresponds to 75m. 
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collected included liver (L), stomach (st), small intestine (si), large intestine (li), 
lungs (lg), heart (h) and in the tissues collected from e12.5 (A) it’s possible to 
identify the ceccum (c). Scale bars are 1 mm for insert A and 2 mm for inserts B 
and C. 
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Fig 4.17 Cell sorting (FACS) of adult ISCs from male Lgr5-EGFP-ires-creERT2 stained 
with EpCAM, CD31 and CD45, and DAPI. Cellular events (A), single cell 
events (B) and Lgr5-eGFP positive events (C) were isolated in order to prepare 
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stained with EpCAM, CD31 and CD45, and DAPI. Cellular events (A), single 
cell events (B) EpCAM, CD31 and CD45 stained cells (C). Living cells 
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prepare a purified cell suspention of the targeted adult ISCs. 
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Fig 4.19 Cell sorting (FACS) of embryonic endothelium cells from small intestine of 
stage e12.5, stained with EpCAM and CD31. Target cells were 
EpCAM+/CD31-. Cellular events (A), single cell events (B) EpCAM, and 
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EpCAM+/CD31CD45-. Cellular events (A), single cell events (B) EpCAM, 
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1. Introduction 
 
Biological systems are in constant search of a homeostatic state. This is the state that 
offers the best conditions in order for the events needed to sustain life occur in a optimal 
manner. There are many ways that a system can regulate itself to maintain its 
homeostatic state while keeping up with the always changing environment. This can 
include adjustments to pH fluctuations, increase or decrease of secretions for pathogen 
elimination, just to mention a few. Even the constant renewal of cells in a tissue is 
important to assure a proper function. 
A tissue where cell renewal is a constant is the small intestine. In this structure, the  
epithelium is the most vigorously self-renewing tissue of adult mammals. The harsh 
conditions to which the tissue is subjected are the reasons for it
1,2
. 
 
1.1 Small Intestine 
 
The small intestine is a highly organized tissue that serve a broad array of functions that 
are mainly absorptive and protective
3,4
. For the most part of the embryonic development 
the gut goes through a series of changes. Throughout the different stages, the small 
intestine accompanies the body’s development, continuing until it reaches maturity. 
While doing so, the gut acquires its final structure the cells lining it start to differentiate 
and to acquire their final identity
4
.  
 
1.1.1 Adult small intestine  
 
The simplest representation of the adult intestinal tract is a tube with a wall composed 
of three different layers
5
 (Fig 1.1 a), each with its own function and characteristics. The 
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outer layer, formed by several sheets of smooth muscle and by the enteric nervous 
system ensures the peristaltic movements of the intestine. Connective tissue with 
numerous blood and lymph vessels, nerve fibers and cells of the immune system 
makeup the middle layer while the most inner layer, the mucosa, consist of a simple 
epithelium responsible by digestion and absorption of approximately 95 % of 
nutrients
2,5,6
. 
The small intestine tube structure is also complemented with a three dimensional 
structure characteristic of the lumen. The presence of finger-like protrusions – villi – 
surrounded in the base by multiple invaginations – crypts of Lieberkühn – increases 
the surface area of the gut
2,5-7
 (Fig 1.1 b). As a consequence, the small intestine is the 
biggest surface between the inside and the outside of the body. Although permeable to 
nutrients and other molecules, it blocks the passage of harmful antigens, bacteria or 
macromolecules
6,8
. Function of the mucosa epithelium is ensured by a variety of 
differentiated cells populating it
2,3,9
.  
 
 
Fig 1. 1: Structure of the adult small intestine in mammals. The small intestine, in its simplest form as a 
tube with several tissue layers surrounding the lumen (a). In the interior of this structure the villus cover 
the internal layer as they project towards the lumen as they are surrounded by the crypts of Lieberkühn 
(b). Image modified from http://www.made4ll.com/anatomy/small-intestine-villi/. 
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In the villi, three main types of epithelial cells are found: enterocytes, goblet cells and 
enteroendocrine cells
1
 (Fig 1.2). Enterocytes are the most abundant cell type found in 
the small intestine with their number being higher in the duodenum. The cells are 
columnar in shape, with a basal nucleus and apical microvilli (that further increase the 
absorptive surface). Besides being responsible for absorption of nutrients and water by 
active and passive transport through the epithelium, these cells secrete a cocktail of 
hydrolytic enzymes into the lumen
2,5,9-11
. Second most abundant cell in the small 
intestine epithelium are the Goblet (or mucosecreting) cells that are found scattered 
from the middle of the crypt up to the tip of the villus. They are characterized by having 
mucigen granules in their cytoplasm, that will be released into the intestinal lumen for 
lubrication and protection of the mucosa and are found in a higher number in the distal 
region of the gut
2,3,5,9,10
. The third type of differentiated cell lining the villi are the 
enteroendocrine. They comprise less than 1% of the total epithelial cells and are 
distributed evenly along the small intestine. Enteroendocrine cells contain numerous 
dense granules containing the secreted peptide hormones, that include serotonine, 
secretine, and substance P, that will control gut physiology
1,5,9,10,12
. 
The rapid self-renewal of the epithelium is orchestrated by the proliferative 
compartment, the intestinal crypts. Here, adult stem cells and Transit amplifying (TA) 
cells will proliferate continuously, generating 250 new epithelial cells per day (Fig 1.2). 
They migrate upwards from the bottom of the crypts up to the crypt-villus junction, 
differentiating along the passage. Cells, that now are completely differentiated, continue 
to migrate upward from the junction until they are exfoliated at the tip of the 
villus
2,6,8,10,13,14
. 
The differentiated cells of the epithelium found in the villi, carry out their function of 
nutrient absorption even though regularly exposed to extremely harsh external 
conditions. Constant attacks of chemical, mechanic or pathogenic nature requires a high 
cellular turnover for the villi to maintain its functions. This means a complete 
epithelium renewal every 3-5 days
7
. 
A forth type of differentiated epithelial cell, Paneth cells (Fig 1.2), are only found in 
the proliferative compartment. In the bottom of the intestinal crypts, Paneth are 
columnar cells with of large secretory granules in the cytoplasm. In the granules, 
specific proteins such as lysozymes, defensins and small molecular weight proteins with 
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antibacterial function, can be found. All these factors together with the fact that Paneth 
cells have phagocytic properties are strong indicators that these cells have a role in 
immunity
1,2,9,10
. 
 
 
 
Fig 1. 2: Representation of the crypt-villus axis in the small intestine. This structure can be divided into 
absorptive and proliferative compartments. In the absorptive compartment, the fully differentiated cells 
(enterocytes, goblet and enteroendocrine cells) carryout the absorptive functions of the small intestine. In 
the second compartment, stem cells and transit amplifying cells divide in order to feeding the renewal of 
the epithelial cells in the villus
15
. 
 
In summary, the small intestine epithelium is a very dynamic tissue. The four main cell 
types are classified into absorptive – enterocytes – or secretory – goblet, 
enteroendocrine and paneth, according to their characteristics
1
. This lining is a very 
specialized barrier protecting the organism from external aggressions resulting in the 
need for a high rate of cell turnover. Fuelling cell renewal are the crypts where 250 cells 
are produced and differentiate every day in each crypt. To reach this dynamic state, the 
intestine goes through several developmental stages as it differentiates from the 
embryonic endoderm
4
. 
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1.1.2 Small intestine in embryos  
 
In the early developmental stages of vertebrate embryos three primary germ layers, 
endoderm, mesoderm and ectoderm arise after gastrulation
4,16
. Formation of the 
primitive gut tube starts with endoderm closure in the anterior and posterior intestinal 
portals continuing toward the middle of the embryo, fusing around embryonic day 8.5 
(e8.5) to e9.0
11,17
 (Fig 1.3)  . Simultaneously with gut tube formation, the epithelium 
elongates along the anterior-posterior axis and undergoes the patterning of the foregut at 
the anterior region, midgut and hindgut
4,11
 at the posterior end of the gut tube. From 
these regions, the endoderm derived organs will develop by local swelling, budding or 
coilling
18
. Foregut will differentiate into thyroid, esophagus, lungs, stomach, pancreas, 
liver, gall bladder and duodenum while the mid and hindgut give rise to the small and 
large intestines, respectively
11
. 
 
Fig 1. 3: Representation of mouse intestinal development in embryo. From e8.0 to e8.5 the primitive gut 
tube is formed with endoderm closure (A). Epithelium elongates and forms a pseudo stratified epithelium 
(B). The primitive gut continues to elongate and at e14.0 the epithelium changes from a thightly packed 
structure to a columnar organization with intraepithelial cavities starting to form (C). Villus start to 
emerge at e15 (D) becoming evident at e16.5 (E). From e17, proliferative cells are restricted to the 
intravillus region – in green (F). Image from Spence et al (2011)4. 
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Once the gut tube is formed, the simple epithelium condenses into a pseudostratified 
epithelium at e9.5. Then, and until e13.5, the intestine elongates together with the 
embryo and both the thickness of the tube walls and the circumference of the lumen 
increase
4,12
. At e14 the stratified epithelium reorganizes changing from a tightly packed 
simple epithelium with the nuclei at several levels to a columnar organization with basal 
nuclei
4
. Simultaneously, secondary lumina (or intraepithelial cavities) start to form in 
deep basal layers of the stratified epithelium while cells from the mesenchyme start to 
condensate and this layer begins to invaginate to form the nascent villi
4,12
. Villus 
emergence is evident in mouse at e15 and progress in a rostral-caudal orientation. At 
this point cell proliferation occurs along the epithelium, reducing as the embryo 
develops. Cells proliferate and differentiate into one of the four main types enterocytes, 
goblet cells, enteroendocrine cell and tuft cells
4
. At e17 proliferating cells are restricted 
to the intervillus region
12
 where they remain until the small intestine continues to 
develop in the postnatal period when crypts develop
12
, hosting the proliferative 
compartment and the stem cells that fuel it (Fig 1.3). 
  
1.2 Stem cells 
 
The ability to self renewal and to be progenitors of all the body’s differentiated cells are 
features that are used to describe stem cells
19,20
.  
Stem cells are present throughout the different developmental stages of an organism 
into and during the adult life. Embryonic stem cells (ESC) as the name indicate, are 
found in the embryos and are classified as pluripotent, as they can give rise to all body 
lineages
21
. Adult stem cells, found in adult, fully differentiated tissues, are classified as 
multipotent. This classification is due to the fact that, adult stem cells can only 
self-renew and differentiate into the different cells of the specific tissue from which they 
were isolated
19,21
.   
 
 
7 
  
1.2.1 Stem cells in adult small intestine 
 
As mentioned in section 1.1.1, the harsh conditions of the intestinal lumen require a 
high cellular turnover for homeostasis maintenance. There are two key “elements” for 
the successful cell renewal of the intestinal epithelium: adult stem cells, or intestinal 
stem cells (ISC), and TA cells.The ISC are confined to the bottom of the intestinal 
crypts and are responsible for continuously providing cells for epithelial renewal. While 
differentiating into one of the intestinal cell lineages, ISC have to keep their population 
thus maintaining the proliferative compartment functional
10
. So far, two models have 
been presented to explain this balance. One of the models, the Deterministic model, 
suggests that individual stem cells divide asymmetrically; one of the daughter cells is 
kept at the bottom of the crypt as a stem cell, contributing for ISC population 
maintenance, while the other migrates into the proliferative zone, becoming a TA 
cell
10,22
. The Stochastic model, on the other hand, hypothesize that stem cells divide 
symmetrically and stay at the bottom of the crypt as stem cells; as stem cells continue to 
divide giving rise to two stem cells they are eventually pushed out of the bottom of the 
crypt and consequently become TA cells
10,23
. 
It has been reported that stem cells divide every 24 hours and that there are 
approximately 10 to 15 stem cells at the bottom of each crypt
22
. With this rates of cell 
division it would not be possible for the ISC per se to give rise to up 300 cells per day
5
. 
Once the stem cells leave the bottom of the crypt they pass into the proliferative zone 
becoming TA cells. The higher division rate these cells present, with cycles every 12 to 
16 hours ensure the high number of cells necessary for the epithelium self-renewal and 
will migrate upwards the crypt walls
5,22
. While doing so, TA cells undergo up to six 
rounds of cell division and start to commit to one of the cell types, until they exit the 
crypt fully differentiated 
2,5
.  
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Fig 1. 4: Intestinal stem cells of the small intestine. The specific location of the stems cells is a topic of 
some discussion with two stem cell populations reported to be present in the bottom of the crypt – crypt 
base columnar (CBC) cells and the +4 cells. Image from
7
. 
Although it has been known that the ISC are located in the bottom of the crypt, their 
specific localization in the crypt has been a topic of some discussion. Two stem cell 
populations have been reported to be present at the bottom of the crypt, the crypt base 
columnar (CBC) cells and the label-retaining +4 cells
24
 (Fig 1.4). Behind the 
description of these two different stem cell populations are the findings of Cheng and 
Leblond (1974) in respect to the stem cell model and the works from Cairnie et al and 
Potten et al (1974) for the +4 model
7
.  
While performing electron microscopy studies in the crypts of the small intestine, 
Cheng and Leblond found that other cells beside Paneth populate the bottom of the 
intestinal crypts
2
. They found slender, immature, cycling cells lodged between the 
Paneth cells that were named CBC cells
24,25
. Another characteristic of this type of cells 
is that they are sensitive to tritiated-thymidine exposure. In their studies, Cheng and 
Leblond also accounted that after exposure the surviving CBC cells phagocyted the 
surrounding damaged cells. In this process radioactive phagossomes appeared in the 
surviving cells. They were present initially only in the CBC cells and progressively 
detected in the differentiated cells as cells divided. Such results were interpreted as 
evidence of stemness of the CBC cells
7,25,26
. The competing +4 model was initially 
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proposed when cell tracking experiments predicted that cells in the crypt had a common 
origin in position 4-5, just above Paneth cells. Additional support to this was given by 
Potten and colleagues which demonstrated that these cells had desirable stem cells 
properties. They were found to be sensitive to X and -radiation and to have 
Deoxyribonucleic Acid (DNA) label retention
25
. Sensitivity to radiation would avoid 
potential carcinogenic genetic abnormalities to be passed throughout the daughter cells. 
Long-term retention of DNA label resulted from the asymmetric DNA segregation 
whereby the template, “immortal”, strands of DNA were retained by the stem cell in the 
+4 position, while the newly synthesized DNA strands would be inherited by the 
daughter cells
2,7,25,26
. 
 
One of the reasons for the difficulty on the identification of ISCs is the lack of well 
validated markers for these cells
3
. 
 
  1.2.1.1 Stem cell markers 
 
Differentiated cells in the intestinal epithelium have been well defined morphologically 
and in terms of molecular markers
3
. Unlike these differentiated populations, such 
definite characterization is not yet possible for the ISCs even though an array of markers 
have been proposed.  
Most efforts were focused in the markers for the +4 population until recently when the 
stem cell zone resurged. This was possible with the identification of the Leucine-rich G 
protein-coupled receptor 5 (Lgr5)/GPR49
2
. Since its identification, this gene was 
included in the list of the potential markers in which are included Bmi 1, mTert, Ascl2, 
Olfm4, Sox9, Musashi-1
2,26
. Nevertheless, Lgr5 is the most promising with given 
evidence as a ISC marker
7
.  
Lgr5 is a 7 transmembrane G-protein with its expression limited to the CBC cells
7
. Cells 
expressing Lgr5 are able to generate all lineages of the intestinal epithelium in-vivo, 
while in-vitro form self-renewing epithelial organoids similar to the crypt-villus axis, as 
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reviewed by Lin and Barker (2011)
25
. In respect to other possible markers identified so 
far, complementary studies show that none of them is either expressed exclusively in 
one of the stem cell populations, or when they are, lineage tracing does not support 
them
25
. 
With different cycling dynamics, radiation sensitivity and response to the signaling 
pathways Lgr5 and +4 cells can be in fact two different populations that complement 
each other. The CBC cells with a higher cycling dynamic repopulate the crypts, 
ensuring the daily renewal of the epithelium and the more quiescent +4 cells act as a 
“reserve” subpopulation that respond in cases of injury or loss of the active stem cells7. 
Nevertheless, with the overlapping expression of Lgr5 with markers associated with +4 
population, it has be hypothesized that in fact these two different stem cell populations 
are the same. In this case the Lgr5+ cells would occasionally acquire +4 characteristics 
to adapt to changes in the crypt environment
24
. 
 
  1.2.1.2 Stem cell niche 
 
At the bottom of the intestinal crypt, ISC are enclosed in the stem cells niche. This 
space provides ISC a very specific and dynamic microenvironment that is responsive to 
environmental signals
15,20
. 
Beside the ISC, several cell types compose the niche. Epithelial, mesenchymal and 
smooth muscle cells, basement membrane and macrophages are part of the cellular 
structure, each contributing in a specific manner
15,27,28
. Myofibroblasts and 
mesenchymal cells, due to their presence in the adjacent lamina propria are in a location 
that allows them to regulate cell behavior in the niche through the action of soluble and 
cell associated factors such as growth factors and cytokines
15,27
. With the combination 
of this factors ISC are regulated in order to maintain their own population, to proliferate 
giving rise to the differentiated progeny or even to respond against any perturbations 
allowing tissue recovery
29
. 
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Small intestine crypts and villi and the diverse cell composition create different regions 
along the gastrointestinal (GI) tract tightly controlled by a complex interplay of the 
major signaling pathways
8
. 
 
1.2 Cell differentiation/specification 
 
The combination of the environmental factors available for niche and crypt control build 
a complex signaling network comprising Wnt/-catenin, Bone Morphogenetic 
Protein (BMP), Hedgehog (Hh) and Notch pathways
27,29
, to name a few (Fig 1.5). 
 
 
Fig 1. 5: Several secreted factors regulate ISCs and distribution of the TA and differentiated cells. The 
Wnt/b-catenin pathway is expressed in a reciprocal gradient to the BMP and Hh pathways along the 
crypt-villus axis, with these last two inhibit the Wnt signaling. Notch expression is higher at the bottom of 
the crypt and as it gradually decreases towards the villi, ISCs differentiate into the secretory lineage
27
. 
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  1.3.1 Wnt/-catenin pathway 
 
Signaling of Wnt/-catenin pathway has effects on cell proliferation, cell survival, cell 
polarity and even cell fate determination
30
. Signaling is ensured by Wnt ligands, a 
family of secreted glycoproteins evolutionally conserved, found in vertebrates and 
invertebrates
27,31
. Generally these molecules have approximately 350 aminoacids (aa) 
with a correspondent molecular weight of ~40KDa and are involved in two major 
pathways
30,31
. 
 
Fig 1. 6: Schematic representation of the canonical Wnt/b-catenin pathway. In the presence of Wnt 
ligands the ubiquitination of b-catenin is blocked and b-catenin translocates into the nucleus. The 
expression of Wnt dependet genes is induced
31
. 
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The pathways activated by the Wnt ligand are known as canonical (-catenin dependent) 
and non-canonical (-catenin independent)30. In the canonical pathway (Fig 1.6), 
activation occurs when a Wnt ligand binds to the seven-transmembrane Frizzled (Fz) 
receptor and its co-receptor Low-density lipoprotein receptor-related protein 6 
(LRP6) or its close relative LRP5
8,32
. In the absence of the activation signal, -catenin 
in the cytoplasm is inactive and it easily captured by the destruction complex formed by 
Axin, adenomatous polyposis coli (APC), casein kinase 1 (CK1) and glycogen synthase 
kinase 3 (GSK3)8. CK1 and GSK3 phosphorylate -catenin in the N-terminal region 
signaling it for ubiquitination preceded by proteasomal degradation. catenin is 
prevented to reach the nucleus thus repressing Wnt target genes
32,33
. In the presence of 
Wnt ligands the Wnt-Fz-LRP6 complex formed recruits the intracellular protein 
Dishevelled (Dvl)
32
. The LRP6 intracellular tail is phosphorilated by Dvl and Axin is 
recruited to this site inhibiting -catenin ubiquitination33. -catenin accumulates in the 
cytoplasm and translocates into the nucleus where it induces the expression of Wnt 
dependent genes by activating the transcription factors of the T-cell factor/lymphoid 
enhancer factor 1 (TCF/LEF-1) family
31,33
.  
In the less studied non-canonical Wnt pathways, Wnt ligand activates the intracellular 
signaling cascade independently of the LRP5/6
30
. Activation of cJun-N-terminal kinase 
pathway or Ca
2+-
dependent pathways occur for the regulation of cell polarity or cell 
adhesion and motility
30,31
. 
In the adult small intestine, Wnt/-catenin is essential for ISC maintenance, 
proliferation and compartmentalization of the crypt and differentiation zones of the 
epithelium
4,34
. The Wnt ligands secreted by the myofibroblasts at the basement 
membrane of basal crypt epithelium creates a signaling gradient of Wnt/-catenin 
pathway along the crypt-villus axis, stronger at the bottom of the crypt
5,27
. Target genes 
of the Wnt/-catenin pathway include c-myc, involved in cell proliferation, EphB2 and 
EphB3, controlling segregation that occurs in the crypt, Sox9, a regulator of Paneth cell 
differentiation, and Lgr5
27
, a cellular receptor for the enhancement of Wnt signaling 
being itself controlled by the Wnt pathway
7,35
. For activation of the Lgr5 amplifying 
system, a exogenous ligand that make part of a small family of R-spondins,  binds to the 
Lgr5 receptors initiating the intracellular signaling cascade
7,8,35
 amplifying the 
Wnt/-catenin signaling.  
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The role of Wnt/-catenin pathway is to be a master regulator of both embryonic 
development and adult tissue homeostasis. Nevertheless, studies have shown that Wnt 
signaling is key for the control of cell proliferation while other pathways regulate other 
processes in tissue homeostasis. Such case is the Notch signaling cascade who’s key 
role is the suppression of cell fate
36
. 
 
1.3.2 Notch pathway 
 
Notch pathway signals for the maintenance of the stem cell signaling network, cellular 
patterning and cell organization within a tissue
4,37,38
. Notch is a highly conserved 
signaling network presenting, in mammals, 4 receptors, Notch 1 to 4, and 5 ligands, 
Delta-like (Dll) 1, 3 and 4, and Jagged (Jag) 1 and 2
36,39,40
 .  
Both Notch receptors and ligands are cell-surface type I single-pass transmembrane 
proteins with a extracellular domain
37,41,42
. Activation of the pathway is a short range 
event through cell-cell interactions between the receptor and the ligand, expressed in the 
neighboring cells
39,40
.   
Notch (receptor) is a heterodimer at the plasma membrane formed by the Notch 
extra-cellular domain (NECD) and a membrane-tethered intracellular domain called 
NTM
42
. Both domains interact to form the heterodimer through a non-covalent 
interaction Ca
2+
 dependent
42
. For activation of the signaling cascade, the ligands of the 
DSL family (Delta, Serrate, Lag) establish a strong ligation with the NECD initiating a 
process involving proteolysis and endocytosis of the receptor
37
. This ligation cause the 
complex receptor-ligand to be available for cleavage by extracellular ADAM 
proteases
36,42
. The complex is sliced and the ectodomain of Notch is released while a 
membrane-bound form of Notch, called Notch extracellular truncation (NEXT) is 
activated. NEXT is further processed through the action of the intramembranous protein 
complex -secretase36,42. This complex cleaves NEXT at two endomembrane sites 
resulting in the release of Notch intracellular domain (NICD) to the cytoplasm
42
. Once 
in the cytoplasm, NCID translocates to the nucleus were it interacts with the DNA 
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binding protein CSL family and recruits the coactivator Mastermind initiating the 
transcription of Notch downstream target genes
37,41
 (Fig 1.7). 
 
Fig 1. 7: Model for the Nocth signaling pathway. The binding of the DSL family ligands initiate the 
signaling cascade triggering the transcription of Notch downstream target genes. Image from 
41
. 
Notch downstream target genes often differ among cell types. Nevertheless, the most 
widely expressed and best characterized target genes of Notch signaling cascade belong 
to the HES/HEY family. One of the major functions of these proteins is the repression 
of transcription factors of the Ascheate-scute like 1 and Neurogenin family. Notch has 
been shown to regulate expression of genes like myc, cyclinD, CDK5 in cell 
proliferation, or cell cycle inhibitors like p21 in cell types that Notch promotes 
differentiation
39
. 
In the small intestine of mammalian, due to the characteristics of this tissue, Notch 
signaling pathway has a dual role
39
. It controls the differentiation of daughter cells into 
enterocytes of the absorptive lineage while, together with Wnt pathway, Notch 
promotes stem cell proliferation
3,39,40
. In the adult small intestine Notch components are 
expressed in the epithelium at the bottom of the crypt in the region of the stem cell
3,40
. 
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On the other hand, in the developing intestine, at E13.5 and E18.5 of the mouse, Notch 
ligands Jag1, Jag2 and Dll1 are predominantly expressed at the mesenchyme
40
. 
 
1.3.3 BMP pathway 
 
BMPs are a family of conserved growth factors and form the largest subgroup of the 
Transcription Growth Factor Beta (TGF) superfamily43,44. They are synthesized as 
large 400-500 aa precursors and are cleaved into 50-100 aa active proteins with seven 
cysteins, of which 6 will form 3 intramolecular disulfide bonds
43,45
. The remaining 
cysteine is key for dimerization with another monomer, forming a covalent disulfite 
bond between both molecules producing homo or heterodimers
43
. 
The role of BMPs is very wide. During embryonic development they influence 
gastrulation, neurogenesis, apoptosis and hematopoiesis
45
. In adult, these proteins are 
involved in homeostasis maintenance participating in tissue remodeling and 
regeneration regulating stem cell properties
46
.  
The BMP canonical signaling pathway functions through a receptor mediated 
intracellular signaling
46
. The signaling cascade is initiated when the extracellular BMP 
ligands bind to the receptor
47
. BMP receptors are formed by type I and type II receptors 
in such way that different combinations of the type II with one of the three type I 
receptors may determine the receptors specificity
46
. When BMPs bind to the receptors, 
it is presumed that a conformational alteration of the type II receptor occurs thus 
activating,  by cross-phosphorylation, type I receptor
43-45
. In turn, the active type I 
receptor transiently associate with receptor-activated Smads (R-Smads, Smad1/5/8) 
phosphorylating and activating it
45,47
. R-Smads are quickly released from the receptor 
and interact with the common-mediator Smads (Co-Smads, Smad4). Two R-Smads and 
one Co-Smad form a complex that translocates from the cytoplasm into the nucleus 
modulating the transcription of target genes
44,46
. 
Although not as well studied as the Smad-dependent pathway, BMPs are able to initiate 
other pathways such as extracellular signal-regulated kinase (ERK), map kinase p38, 
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C-jun N-terminal kinase (JNK), and nuclear factor kappa beta (NFB). Through these 
pathways, BMPs are involved in cell survival, apoptosis, migration and differentiation
43
. 
In the small intestine several pathways are involved in the regulation of stem cell self-
renewal with each cascade playing either different or overlapping roles
46
. In the case of 
the BMP pathway, this is involved the regulation of stem cell proliferation by inhibiting 
it
27
. The BMP ligands 2 and 4 mainly synthesized and released by the cells of the 
intervillus mesenchyme at the villus tips. They decrease in number towards the crypt 
and BMP receptors found along the villus epithelium
13,27
 BMP signaling overlaps with 
Hh and Wnt pathways
13,27
. By mediating the action of the Hh pathway formation of 
ectopic crypts is avoided, thus restricting crypt numbers, while, by suppressing Wnt 
cascade signaling stem cell, self-renewal is balanced
13,27
. 
 
1.3.4 Hh pathway 
 
The Hh proteins provide a critical signal for the proper embryonic development to  
occur
48
. During these critical developmental stages, Hh proteins are involved in the 
patterning of the neural tube, lung, skin, axial skeleton as well as the GI tract
48
. In the 
adult tissues, on the other hand, Hh are still present even though only involved in stem 
cell maintenance, proliferation and differentiation
48,49
. 
In mammals there are 3 members of the Hh family: Sonic Hedgehog (Shh), Indian 
Hedgehog (Ihh) and Desert Hedgehog (Dhh)
50
. They are synthesized as precursor 
proteins of about 45 kilodalton (kDa) that undergo autocleavage yielding an amino-
terminal polypeptide and a carboxy-terminal polypeptide
51,52
. The N-terminal 
polypeptide, now with about 19 kDa, is modified with a cholesterol molecule added in 
the C-terminus and a molecule of palmitic acid at the N-terminus
48,52
. With this dual 
lipid modification, Hh proteins have their membrane association enhanced also 
affecting their secretion and action range
52
. This culminates with the secretion of the Hh 
proteins from the cell through the activity of the multipass transmembrane protein 
Dispatched (Disp)
52
. 
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Until the Hh ligands binds to Patched (Ptch), a 12-span transmembrane protein receptor, 
the Hh cytoplasmatic signaling cascade is inhibited by the repression of another 
transmembrane protein, Smoothened (Smo)
50,53
. When a Hh ligand associates with the 
receptor Ptch, this complex is internalized resulting in the loss of activity of Ptch and 
Smo repression ends, initiating the signaling
49,51
. 
The de-repressed Smo signals for the activation of STK36 serine/threonine kinase
53
. In 
turn, the formation of the GLI degradation complex is inhibited, preventing the 
phosphorylation of the glioma-associated (Gli) family proteins (Gli 1 to 3) by the 
complex and consequent ubiquitination and degradation
50,53
. Proteins of the Gli family 
are zinc finger transcription factors that when are not degraded translocate to the 
nucleus regulating the transcription of genes such as Gli1, Ptch1, CCND2, FOXL1, and 
JAG2
50,53
. 
In the small intestine, the relevance of Hh pathway starts very early, being critical for 
the normal development and for the establishment of villus and crypts. During the 
development of the mouse embryo, the epithelium expresses Shh and Ihh, signaling for 
the receptors in the mesenchyme
13,54
. As the intestine develops, the expression of these 
ligands becomes restricted to the intervillus regions
13
. In the adult small intestine, 
expression of Shh and Ihh is maintained in the regions that derive from the intervillus 
regions – the crypts, where proliferation is present13. Its presence here is of great 
importance for the inhibition of the Wnt canonical pathway, thus regulating stem cell 
proliferation in the crypts
52,53
. Also, Hh pathway signals for the regulation of the BMP 
pathway controlling the crypt population
52
. 
 
  1.3.5 Eph/ephrin pathway 
 
Erythropoietin-producing hepatocellular (Eph) receptors are type-I transmembrane 
protein and, together with its ligands, comprise the largest subfamily of receptor 
tyrosine kinase (RTK) with 14 members
55-57
.  
Relevance of Eph receptors in homeostasis maintenance can be noted by the biological 
activities they have been implicated so far. Eph receptors are reported to have effects on 
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actin cytoskeleton, cell-substrate adhesion, cell shape and cell movement, as well as cell 
proliferation, survival, differentiation and secretion
58,59
. 
The extracellular domain of the receptor (N-terminal) contain a high affinity binding 
site for interaction with the ligands, Eph receptor interacting proteins (ephrins)
58
. 
Ephrins are, in turn, also cell surface-bound proteins that, due to structural differences 
are divided in two classes: class A, anchored to the plasma membrane through a 
glycosylphosphatidylinositol (GPI); and class B, are transmembrane proteins with a 
small cytoplasmatic tail
56,60
. When the ephrins bind to the respective receptor, 
phosphorylation of the kinase domains occur, at the intracellular region
57,60
. 
Conformation of the receptors and ligands occur as well as multimerization and 
clustering and the active kinase phosphorylates other molecules triggering the 
downstream cascade
57,60
.    
One of the major distinctive characteristic of the Eph/ephrin signaling is the generation 
of bidirectional signaling: both receptors and ligands are able to transduce a signaling 
cascade activated upon receptor-ligand biding
56,58
. This property, together with the 
multimerization of the Eph/ephrin complex result in its biological roles
60
. As the Eph 
receptors phosphorylate downstream molecules, in turn signal through a wide set of 
pathways. The cascades that are activated include H-Ras and MAP kinase pathway 
(transcription regulation, proliferation and cell migration), Jak/Sak pathway and PI3K 
pathway (promoting proliferation)
60
. This highlights how the Eph/ephrin is a part of a 
very complex network of signaling cascades
56
.  
In the small intestine, epithelial homeostasis is mainly regulated by the Wnt pathway, in 
part by controlling the balance in the expression of Eph receptors and ligands. As the 
TA cells migrate, they move away from the Wnt signaling, consequently, EphB 
expression decreases and ephrin-B expression increases
58
. 
 
As described in the previous sections, signaling pathways are key for the maintenance 
of tissue homeostasis, ensuring that stem cells are maintained, proliferate and 
differentiate in a orderly manner. It is important to note that some of these pathways 
begin to be expressed at early developmental stages. In doing so, they contribute to the 
correct development of the animal.  
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The control of gene expression during the several developmental stages has to be tight 
to ensure a balance between stability and plasticity
61
. To this effect DNA 
post-transcriptional modifications contribute to gene regulation
61
. These modifications 
are termed Epigenetic modifications. 
 
1.4 Epigenetics 
 
As cells multiply and differentiate, either during embryonic development or adult stem 
cells, gene expression modifies. Some of the genes are activated while others are 
deactivated
62
. This results in a tight gene expression program specific to a population of 
cells at a given developmental stage allowing a balance between stability and 
plasticity
61
. Nevertheless this all happens without changes in the DNA sequence. The 
reprogramming that is carried out is a result of epigenetic modifications to the DNA
62
. 
Epigenetics has been defined as changes in gene expression that do not result from 
changes in nucleotide sequences and are mitotically and/or meiotically heritable
63-65
. 
They are under the effects of environmental cues and are key for regulation of tissue 
and cell-type specific gene patterns
63,66
 (Fig 1.8).  
 
Fig 1. 8: Epigenetic mechanisms and the link between environmental factor and phenotipical alterations
66
. 
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1.4.1 Epigenetic Modifications 
One of the challenges in understanding epigenetics is the balance required, each time a 
SC divides, how the factors will define whether a daughter cell differentiate or 
maintains its plutipotency
65
. 
This process is triggered at the very early stages of an organisms life. Shortly after 
fertilization in mammals both (highly specialized) parental genomes combine to give 
rise a totipotent embryo, through epigenetic rearrangements
62
. 
The best-known epigenetic modifications are DNA methylation, changes in chromatin 
due to histone modifications and the less understood microRNA
63-66
. 
 
 
 1.4.1.1 DNA methylation 
The best known epigenetic modification is DNA methylation
65. It’s the result from the 
covalent binding of a methyl (CH3) group to a cytosine in the 5’ position, at a cytosine 
in the dinucleotide cytosine-phosphate-guanine (CpG)
67,68
.  
Changes in DNA methylation pattern occur through life span. It starts upon fertilization, 
when gametes methylation signatures are erased and de novo patterns are established
66
. 
At this point, DNA methylation is very low in the stem cells, increasing throughout 
cellular differentiation
61
.  
In the majority of mammal cells, 70 to 80% of the CpGs found in the genome are 
methylated, despite the CpGs that are isolated, clustered or found in a CpG island (DNA 
region with a high concentration of the dinucleotides)
65,67,68
. 
Nevertheless, the main indications that DNA methylation is involved in the control of 
gene expression, come from the fact that certain regions are protected from methylation. 
The majority of those regions are CpG islands in the 5’ end of 60% of human genome 
that usually comprise promoter and first exon of a gene
65
. When one of this regions 
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become methylated during the developmental or differentiation stages, long term gene 
expression is silencing occurs
65,67
.  
The reaction leading to cytosine methylation is catalyzed by DNA methyltransferases 
(DNMTs). These enzymes are responsible for maintenance, DNMT1 – ensuring the 
maintenance of methylation patterns through the cell division; or de novo methylation, 
DNMT3A and DNMT3B, that are able to set new methylation marks in unmodified and 
hemimethylated cytosines
62,66,68
.The presence of the methyl groups in the DNA 
sequence is believed to prevent the transcription factors to bind to it or to facilitate the 
assembly of repressor complexes
69
. 
Detection methods for the study of methylation patterns in gDNA include bisulfate 
sequencing, methylation-specific PCR, restriction landmark genomic scanning and 
differential methylation hybridization
65
. 
Although important, DNA methylation is not the only factor in the repression of gene 
transcription. Histone modifications is also needed for this regulation mechanism
62
. 
 
1.4.1.2 Histone modifications 
In order to keep the long DNA strands packed in the cell nucleus, associated proteins 
are required. This complex system of DNA and proteins make up chromatin and it has 
the ability to alter transcriptional activity as result of modifications on its structure
65
. 
The basic structure of chromatin is the nucleosome
65
.  Each nucleosome is a octamer 
with two of each of the four core histones, the proteic building blocks of DNA 
packaging: H2A, H2B, H3 and H4
66,68
. These proteins have two domains, global and 
tail. The latter is the main target of posttranslational modifications
63
. Such modifications 
are the key for chromatin condensation, replication, DNA repair and transcriptional 
regulation and are the result of changes in the ionic charge of the histones tail or by 
serving as platform for other proteins to bind into
63,66
. Among the histone modifications 
that include acetylation, methylation, phosphorylation, ubiquitination and sumoylation, 
the most well studied in the field of Epigenetics, are the changes in methylation and 
acetylation of histones H3 and H4
66,67
. 
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Much like with DNA methylation, chromatin structure changes throughout development 
and/or differentiation. It starts as a permissive structure in multipotent cells that 
progressively closes during differentiation
69
. 
The study of histone modification, the chromatin immunoprecipitation (ChIP) method is 
key. In this method the cells are treated with formaldehyde to crosslink DNA and 
histones. This ligation will be removed after gDNA is fragmented and the fragments 
that are not bound to DNA-binding proteins are removed from the solution. Two 
downstream methods were developed to identify the potential sequences associated to 
the histones
65
. One of the methods, known as ChIP-chip uses microarrays to identify, 
through hybridization, the DNA regions which were bound to histones. The other 
method uses the new sequencing technologies to directly identify the DNA regions that 
were associated to the histones
65
. 
 
1.4.1.3 MicroRNAs 
MicroRNAs are endogenous noncoding RNAs of 19 to 25 nucleotides (nt) long
65
. These 
small single stranded molecules, although not coding for proteins, regulate mRNA 
translation into proteins. This regulation occurs when one of the microRNAs bind to the 
3’-UTR (untranslated region) of a given mRNA, preventing the protein synthesis68. 
Although microRNAs act downstream from the other epigenetic factors (DNA 
methylation, histone modifications) they are epigenetic factors and are under the 
influence of certain environmental factors
66,68
. Studies indicate that there is a balance 
established between microRNAs, DNA methylation and histones. For example DNA 
methylation and histone modifications are able to regulate microRNA’s transcription, 
while some microRNAs can regulate the expression of DNMT3A and DNMT3B as well 
as Polycomb group genes (key enzymes for regulation of histone modifications)
66
. 
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2. Objective 
 
The study that this thesis reports to, consists in one step of a project on the genetic and 
epigenetic changes in the small intestine in mice. The project has been and continues to 
be developed at the Group of Epigenetic Regulation of Transcription in Mouse 
Development and Disease - Institute of Molecular Biology (IMB), Mainz, Germany.  
 
 2.1 Project background 
As the small intestine develops and matures, several gene cascades are activated, 
deactivated or gradually restricted to a small niche. This project’s broader goal is to 
understand gene expression in the stem cells during the developmental process. 
The first approach for this project consisted in the isolation of intestinal stem cells from 
embryo small intestine, e12.5, and adult small intestine, specifically Lgr5 producing 
cells. Once the cells were isolated, RNA was extracted and sequenced, thus providing 
important information about genes that were being expressed at those moments. 
Based in RNA-seq information, validation of the data was necessary, which was 
developed by C. Krienke. In her study, some of the genes differentially expressed, 
according to the RNA-seq data, were selected and in-situ hybridization and real-time 
Polymerase Chain Reaction (qPCR) were performed, successfully validating RNA-seq 
data. 
 The study by C. Krinke was a corroboration of the main purpose of this project, 
allowing the pursue of answers to broader questions such as:  
 How does gene expression change during the embryonic development of the 
small intestine?  
In a embryo, the small intestine, starts as a very simple structure that as the 
embryo develops acquires a three-dimensional arrangement, accompanied with 
cell specification. It will be of great interest to understand how these processes 
modify throughout the developmental stages until adulthood. 
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 Which are the genetic mechanisms that control the activation and deactivation of 
the gene networks involved in the development and differentiation? 
Regulation of gene expression is dependent of several markers that, although not 
altering the DNA structure, alter the availability of certain regions of the 
molecule to the binding of transcription factors. Taking this into consideration in 
the developmental stages, having new data regarding this processes could be 
valuable to understand how stem cells maintain their characteristics and 
differentiate into mature cells. 
 
2.2 Goal 
 
In order for an organism to reach a mature and fully functional state, a series of events 
had to occur. The transition from a fertilized egg into the complex organism in the adult 
stage, is the result of a continuous process controlled by key factors in a genomic level. 
As new research approaches are being followed, they contribute to understand that the 
genomic information is dependent of other factors for its regulation – Epigenetic 
markers.  
The goal of the present study was the analysis of genomic DNA (gDNA) methylation in 
the stem cells of the small intestine in different developmental stages: embryonic and 
adult. By focusing in the embryonic stages e12.5 and e14.5, and in the adult ISC and 
fully differentiated enterocytes we aimed to detect the changes in the methylation 
pattern and attempt to find an association to the changes in RNA expression previously 
detected. 
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3. Methodology 
 
This study focus on the in vivo differences of stem cells found in the small intestine of  
mouse embryo and adult. In order to gather more information about the processes 
involved in stem cell maintenance and differentiation, cells were isolated from untreated 
mice. 
In this experience adult male of the Lgr5-EGFP-ires-creERT2 (Jackson Laboratories) 
strain were the source of the adult ISC. The choice of this strain was based in the 
Lgr5-EGFP construct in which the expression of EGFP is under the control of Lgr5 
promoter, allowing an easier identification of the adult ISCs. On the other hand, for the 
collection of endodermal embryonic stem cells, C57BL/6 females were sacrificed and 
the embryos collected and dissected at the proper developmental stage (established by 
vaginal plug).  
Histological sections were prepared to assess morphological development and correlate 
the developmental stage with the activation or deactivation of gene expression. In-situ 
hybridization (ISH) was performed at e12.5, e13.5, e14.5 and e15.5 and also in sections 
of adult small intestine. 
To analyze changes in the gDNA methylation, stem cells were isolated from adult and 
embryo (e12.5) small intestine, through fluorescence activated cell sorting (FACS). 
From the isolated cells, gDNA was isolated and purified for further analysis by 
Methyl-CpG binding domain protein sequencing (MBD-seq) and Bissulfide conversion.  
 
3.1 Sampling 
Mice, male or female, were sacrificed by hypoxia with CO2 followed by cervical 
dislocation.  
Male Lgr5-EGFP-ires-creERT2 were dissected. Dissection was initiated with a small 
abdominal incision that was gradually increased until whole abdominal cavity exposure. 
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Small intestine was isolated from the GI tract and placed in a petri dish with PBS
1
 1X. 
The small intestine was cut longitudinally, washed in PBS 1X several times to remove 
maximum of fecal matter. Tissue was sectioned into smaller fragments and prepared for 
further processing – ISC isolation or histology. 
Following euthanization, female mice were also dissected in order to expose the 
abdominal cavity. Uterus was removed and placed in PBS 1X. Embryos were dissected 
under a Leica M80 (Leica Microscopie + Systeme GmbH, Germany). Embryos, in the 
amniotic sac, were exposed, collected and placed in PBS 1X. Embryos were decapitated 
and further processed either for embryonic ISC isolation or histology. 
 
3.2 Histochemistry 
 
In this study, the histochemistry technique used was the in-situ hybridization. This 
approach is used as tool to study gene expression in tissues and cell types
70
. Another of 
its valuable features lies in the spatial information retrieved in respect to gene 
expression. In histological sections the cells with the target messenger RNA (mRNA) 
will be identifyed
71
. 
The process through which ISH detects the presence of a target mRNA in a sample is by 
the annealing of a complementary RNA (cRNA) to the target in the cell expressing it. 
As the cRNA chains are labeled with a detectable tag, when they became visible, it is 
possible to assess the distribution of the target mRNA
71
. Initially tags were radioactive 
labels and detection was only possible through autoradiography
71
. New non-radioactive 
labels have been developed with the advantage of being non-radioactive. These labels 
use chemical modifications to the nucleotides used in the synthesis of the 
complementary chain. Such chemical modifications include digoxigenin (DIG), 
dinitrophenol (DNP) and fluorescein
71
. For detection, probes labeled with DIG have to 
be processed using immunohistochemical (IHC) techniques, with anti-DIG antibodies 
coupled to an enzyme that is able to catalyze a cromogenic reaction when a subtract is 
                                                          
1
 Vide Annex for PBS preparation 
2
 Vide anex for plasmid vector map and reference points 
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added allowing the detection of the target mRNA
71,72
. On the other hand, probes that 
use fluorescein as  marker, have the advantage of direct visualization
72
. 
In this study, ISH was performed in paraffin embedded sections of mouse embryos (at 
different developmental stages) and adult small intestine. Probes were prepared using 
DIG as a marker and detection was possible using anti-DIG antibodies coupled with 
alkaline phosphatase. 
 
3.2.1 Tissue processing  
Embryos and adult small intestine collected as described in section 3.1 were initially 
fixed, in order to maintain tissue structure while ensuring nucleic acids stability
72
. This 
was followed by tissue dehydration and paraffin embedding previous to paraffin block 
preparation. 
In order to the fix the tissues, samples were placed in 4% paraformaldehyde (PFA) 
(Sigma Aldrich, Germany) at 4ºC overnight, followed by two washes in PBS 1X, 10 
minutes (min) each. Dehydration was performed with 2 incubations, 2 hours each, in 
70% methanol (Carl Roth GmbH, Germany) in PBS 1X followed by 2 incubations 
100% methanol (Carl Roth GmbH, Germany) also  two hours each. Paraffin embedding 
was initiated by transferring  samples to xylol (Carl Roth GmbH, Germany) for 15 min, 
twice, a 2 hours incubation in paraffin (Carl Roth GmbH, Germany) at 58ºC, followed 
by an overnight incubation at 58ºC in fresh paraffin. Once the samples were embedded 
in paraffin, blocks were prepared in a Leica EG1150 H Paraffin Embedding Center 
(Leica Microskopie + System GmbH, Germany) with special attention to embryo 
positioning, to allow sectioning to be preformed along an anterior to posterior 
orientation.  
Serial sections, 5 to 6 from each stage, 10 m thick, were obtained from each block in a 
Leica RM 2255 Microtome (Leica Microskopie + System GmbH, Germany) and 
mounted in SuperFrost Ultra Plus (Thermo Scientific, Germany) glass slides. As 
sections were being prepared they were observed under a Leica DM750 microscope. 
This ensured that the sections obtained were restricted to the embryo’s abdominal 
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region containing the small intestine. Slides were allowed to dry at room temperature 
(RT) and stored, also at RT, until required. 
 
3.2.2 In-situ Hybridization 
The in-situ hybridization technique used a complementary RNA strand labeled with 
digoxigenin, that hybridized with its complementary mRNA sequence present in the 
tissue. The strategy used for this technique was the use of an anti-digoxigenin antibody 
that bind to the probe’s label and is conjugated with an alkaline phosphatase (AP). 
Addition of BCIP (5-brom-4-chlor-3’-indolyl phosphatase) allowed AP to produce an 
intermediate that underwent a dimerization producing an indigo dye with the release of 
H
+
. The free ions reduce NBT (nitro-blue tetrazolium chloride) to NBT-Formazan thus  
indicating the transcript location in the tissue. 
Preparation to the ISH on slides included fragment amplification of the target gene, 
fragment ligation to a cloning vector - plasmid, transformation of competent cells with 
the ligation product and culture, small scale plasmid DNA (pDNA) preparation 
(Miniprep), sequencing, large scale pDNA preparation (Midiprep), pDNA digestion, 
reverse transcription and probe labeling and probe purification.  
Genes chosen to be analyzed in this study were Mucin 4 (Muc4), Sushi containing 
domain 4 (Susd4), Insulin growth factor binding protein 5 (Igfbp5), Dual specificity 
phosphatase 1 (Dusp1), B-cell translocation gene 2 (Btg2), Achaete-scute complex 
homolog 2 (Ascl2), Inhibitor of DNA binding 2 (Id2), Rik, Notch2, Zinc finger protein 
36 (Zfp36), Shh and Neurogenin 3 (Ngn3). 
 
3.2.2.1 Fragment amplification 
From the RNA-seq tracks obtained as result of the first tasks of this project, target genes 
were selected based in the expression profiles. Genes with higher expression in one of 
the stages, e12.5 or adult ISC, were selected to be analyzed by ISH. 
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With the exception of the Ngn3, all the gene fragments had been amplified and cloned 
by elements of the laboratory. For this reason, amplification protocol will only be 
described focusing on the Ngn3 gene. 
In order to amplify a fragment of the gene Ngn3, it was required to used the Polymerase 
chain reaction (PCR) technique. PCR refers to an in vitro process that enables the 
generation of large amounts of a specific DNA sequence, from a small amount of 
template DNA. For this reaction to occur its required the presence of two synthetic 
oligonucleotide primers that flank the target sequence and are complementary to the 
opposite strands, with the 3’ hydroxyl ends oriented toward each other; a DNA 
template containing the target sequence to be amplified, in this study, gDNA; a 
thermostable DNA polymerase able to withstand multiple cycles of heating up to 95ºC; 
the four deoxyribonucleotide triphosphates, dNTPs, (Adenine, A, Tyrosine, T, 
Guanidine, G, and Cytosine, C). 
A initial denaturation step starts the process, with the temperature being raised to 
about 95ºC to denaturate the template DNA eliminating secondary structures. Synthesis 
cycles are also initiated with a denaturation step that is followed by a renaturation or 
annealing step. In this second step the reaction temperature is slowly cooled to 
temperatures around 55ºC (varying according to primer optimization) allowing for the 
primers to pair in the template DNA chain. When the ligations are stable, the synthesis 
or extension step is initialized. In order to the synthesis of the new DNA fragments to 
take place, reaction temperature is raised to ≈72ºC, maximizing catalytic activity of Taq 
DNA polymerase to extend the chains
73
. The repetition of these steps in a limited 
number of cycles (usually 20-35) will increase the amount of target DNA in a 
exponential manner, as the amount of DNA duplicates in each cycle. 
 
  3.2.2.1.1 Primer design     
Design of the specific primers for the Ngn3 gene was performed using the software 
Primer Premier™ (Biosoft International). Several potential primers were produced. The 
pair of primers that was chosen was the one with less or most instable secondary 
structures (such as dimmers and hairpins), low probability of false priming and targeting 
other regions on the DNA, which was determined by sequencing analysis. 
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The sequences of the primers used for the Ngn3 are presented in table 3.1.   
Table 3. 1: Sequences of the specific primers, forward (Fw) and reverse (Rv) for amplification of Ngn3 
fragment by PCR and predicted size of the fragment (in base pairs, bp). 
Primer Sequence (5’→ 3’) Size (bp) 
Ngn3_Fw CACTCAGCAAACAGCGAAGA 
608 
Ngn3_Rv AAAGCCAGAAGAGGCGAGAT 
 
  3.2.2.1.2 Amplification conditions 
 The cycling conditions for the PCR amplification of the Ngn3 fragment were as 
described in table 3.2.  
Table 3. 2: PCR cycling conditions for amplification of a Ngn3 fragment with specific primers. Data 
refers to temperatures (in ºC), duration of each step (in min or seconds, sec) and also the number of cycles 
to each set of  denaturation, annealing and extension steps. 
Temperature (ºC) Duration Number of cycles 
94 4 min  
94 1 min 
x 2 cycles 65 1 min 
72 1min 
94 30 sec 
x 33 cycles 65 30 sec 
72 30 sec 
 
Reaction mix for Ngn3 PCR was as indicated in table 3.3.  
Table 3. 3: Reaction Mix for Ngn3 fragment amplification by PCR. Primers were those described in table 
3.1 (Sigma-Aldrich, Germany), Taq polymerase and Reaction buffer were from the EpiMark Hot Start 
Taq kit (New England Biolabs, Germany) and template gDNA from adult mouse tails digested with 
proteinase K. 
Reaction components Volume per reaction 
(l) 
EpiMark Hot Start Taq Reaction Buffer 5X 5 
dNTP Mix (10 mM) 0,5 
Primer Fw (10 M) 0,5 
Primer Rv (10 M) 0,5 
Taq DNA polymerase 0,25 
gDNA 0,5 
miliQ water 17,75 
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PCR reaction was carried out as described previously in a thermocycler (Thermocycler 
TProfessional TRIO, Biometra GmbH, Germany). Products of the PCR reaction were 
analysed by eletrophoresis in a 1% agarose (AppliChem GmbH, Germany) gel stainned 
with ethidium bromide (AppliChem GmbH, Germany). To the PCR reaction tubes 10 l 
of 6X Orange DNA Loading Dye (Fermentas) were added, and the final volume was 
loadded into the gel. Amplicon visualization was carried out in a Chemidoc XRS 
system (Biorad, Germany). 
The electrophoresis while confirming the success of the reaction in respect to the 
fragment of interest, also allowed the separation of the target DNA from primers, 
dNTPs, and/or non-specific products.  
  
3.2.2.2 Fragment purification 
The DNA fragments that, in the electrophoresis gel, had the expected size were excised 
from the gel and purified using PeqGOLD Gel Extraction kit (PeqLab, Germany). 
Purification was carried out according to the manufacturer’s instructions. Briefly: the 
excised fragments were placed in centrifuge tubes and weight. To each 0.1g of gel, 
100 l of binding buffer and the mix was incubated (55 to 65 ºC) until the gel was 
completely melted. A column, provided in the kit, was placed in a 2 ml collection tube 
and a maximum volume of 750 l of gel and buffer were transferred and loaded into the 
column. The column and the tube were centrifuged for 1 min at 10000g and the 
flow-through discarded. This step was repeated until all the gel and buffer mixture was 
loaded into the column. Then, 750 l were added to the column and centrifuged for 
1 min at 10000g and the flow-through discarded. This step was performed twice. The 
columns were dried with a centrifugation of 1 min at 10000g. Columns were transferred 
to a fresh tube and 50 l of elution buffer were loaded into the column. Samples were 
collected with a centrifugation for 1 min at 5000g. 
Following purification, samples were quantified using the spectrophotometer Nanodrop 
(Thermo Scientific, Germany) prior to ligation to the cloning vector. 
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3.2.2.3 Cloning 
Molecular cloning is the process during with a fragment of DNA is inserted in a cloning 
vector, such as a plasmid, in order to increase the number of copies of the fragment of 
interest. This is usualy achieved by inserting the vector is a host. The most commonly 
used are bacteria
74
. 
A plasmid cloning vector possesses speficic features that include a small size, needed to 
maximize the transfer efficiency of exogenous DNA into the host bacteria like 
Escherichia coli (E.coli), as it decreases with plasmids that are larger than 15 kilobase 
(kb) long; a multiple cloning site (MCS), where to insert the DNA fragment, flanked by 
sereval recognition sites for restriction endonucleases; and one or more genetic markers 
that allows the identification of cells that carry the cloning vector-insert DNA contruct
73
. 
In this study, the cloning vector used was pGEM-T
2
 (Promega GmbH, Germany). This 
plasmid allows the direct cloning of PCR products with 5’-A residues at the extremities 
as result of the 5’→3’ exonuclease activity of some DNA polymerases. With this 
enrichment of the 5’ extremities, the DNA fragments amplified by PCR, are 
complementary to the 3’-T extremities of the cloning vector. This greatly improves 
ligation efficiency by the enzyme T4 DNA ligase. Another characteristic of this plasmid 
is that the MCS is located within the -peptide coding region of the enzyme 
-galactosidase (lacZ). When the DNA fragment is successfully ligated to the vector, 
this coding region is blocked and -peptide is inactivated. As a result, the transformed 
cells that are grown in the presence of the lac operon, isopropyl--D-
thiogalactopyranidose (IPTG) and the substrate 5-bromo-4-chloro-3-indolyl-b-D-
galactopyranoside (X-Gal), are not able to synthesize the -peptide, enabling them to 
hydrolyze the X-Gal in the growth media. Thus the colonies appear white
73
.    
The ligation reaction was carried out according to the manufacturer’s instructions, with 
a fragment excess of 6:1, to increase ligation success. Ligation mix was carried out as 
described in table 3.4. 
                                                          
2
 Vide anex for plasmid vector map and reference points 
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Table 3. 4: Components (volumes in l) of the reaction mix for the ligation of the Ngn3 fragments, 
amplified by PCR and purified, in the plasmid pGEM-T (Promega). 
 Volume (l) 
2x Rapid Ligation Buffer 5.0 
pGEM-T 1.0 
Insert (Ngn3 fragment) 1.5 
T4 DNA ligase 1.0 
Water 1.5 
Final volume 10.0 
 
Reaction mix was incubated for 1 hour at room temperature and then used for the 
transformation of the competent cells. 
 
3.2.2.4 Transformation of competent cells  
The process of introducing DNA into a bacteria cell is named Transformation and the 
cells that are able of taking this new genetic material are said to be competent. Bacteria 
competence is due to altered cell walls that do not represent an efficient barrier against 
DNA uptake
73
. 
The bacterial cells used in this study were from the strain E.coli DH10B (Invitrogen, 
Germany), previously treated for competence by the calcium chloride (CaCl2) method
3
 
and aliquoted by a member of the Group of Epigenetic Regulation of Transcription in 
Mouse Development and Disease.  
For bacterial transformation, 5 l of the ligation mix (section 3.2.2.3) were added to 100 
l of E.coli DH10B cells and incubated on ice for 10 min. Cells undertake a heat shock 
with a 1,5 min incubation at 42ºC and placed on ice. Then, 1 ml of Luria-Bertani (LB) 
broth were added to the cell suspension and incubated at room temperature for 1 hour. 
Bacteria were plated in LB agar plates with ampicilin (50g/ml) supplemented with 
IPTG (1mM) and X-Gal (20g/ml) and incubated at 37ºC overnight (O/N) 
                                                          
3
 Vide anex for the protocol on CaCl2 competence method 
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Following incubation, plates were analyzed and the number of white colonies (with 
insert) and blue colonies (without insert) evaluated. 
 
3.2.2.5 Miniprep 
 
In order to extract the pDNA from the recombinant bacteria, the method of alkaline 
lysis was applied. In this method an alkaline solution (sodium hydroxide, NaOH) and a 
detergent (sodium dodecyl sulphate, SDS) are added to the cells to disrupt the cell walls 
and dissolve it, thus releasing the genetic material to the solution. 
To purify the pDNA with the cloned Ngn3 fragment, 4 white colonies, from section 
3.2.2.4, were isolated and transferred from the plate. Each colony was inoculated into 
3 ml of LB broth, supplemented with ampicilin (50g/ml) and incubated O/N at 37ºC, 
with agitation. 
Cultures were transferred to 2 ml centrifuge tubes, centrifuged at room temperature for 
5 min. The supernatant was discarded and the pellet resuspended in 100 l of 50mM 
Tris-HCl, pH8/10mM EDTA. To the resuspended pellet, 100 l of 0.2M NaOH/SDS 
1% were added and the mix incubated at room temperature. To neutralize the solution, 
150 l of potassium acetate (KAc) 3M, pH 5,5 were added. The solution was mixed by 
inversion until flocculation. Tubes were centrifuged at maximum speed for 10 min, at 
room temperature. The supernatant was transferred to a fresh tube, 0.7V of isopropanol 
(Carl Roth GmbH, Germany) were added and mixed by inversion. Tubes were 
centrifuged at maximum speed for 25 min, at room temperature. The supernatant was 
then removed and discarded and the pellet washed. Pellet washing was carried out twice 
with the addition of ethanol (Carl Roth GmbH, Germany) 70% and centrifuged at 
maximum speed for 5 min, at room temperature. Supernatant was discarded, the pellet 
allowed to dry  and resuspended in miliQ water. 
Once resuspended the samples were quantified by spectrophotometry with Nanodrop 
and stored until further use. 
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The purified pDNA with the Ngn3 fragment inserted were sequenced at GATC Biotech 
(Germany) facilities, using SP6 primers to confirm their identity and orientation. 
 
3.2.2.6 Midiprep 
 
Once the identity of the cloned fragment was confirmed, a larger scale preparation of 
plasmid DNA was required. To achieve this goal, midiprep was performed.  This 
protocol was used to prepare pDNA with the Ngn3 fragment and also for the other 
genes, mentioned on section 3.2.2. 
To prepare the midipreps for the genes Muc4, Susd4 Igfbp5, Dusp1, Btg2, Ascl2, and 
Ngn3, the peqGOLD XChange Plasmid Midi kit (PeqLab Biotechnologie, Germany) 
was used according to the manufacturer’s instructions. This protocol is based in the 
alkaline lysis method but it has the binding of the pDNA to an anion exchange resin 
under specific low-salt and pH conditions. Briefly, the transformed E.coli were 
inoculated in 100 ml of LB broth, incubated O/N at 37ºC with agitation (200 rpm). Cell 
suspension was transferred to 50 ml Falcon tubes and centrifuged for 10 min at 4300 
rpm, at 4ºC. Supernatant was discarded and the pellet resuspended with 4 ml of Solution 
I/RNase A (provided by the kit). This was followed with the addition of 4 ml of solution 
II (from the kit) and all components were mixed by inversion. Mix was incubated for 5 
min at room temperature and 4 ml of solution III (provided in the kit) precooled were 
added to the suspension the solution was mixed by inversion and centrifuged for 20 min 
at 4ºC at 4300 rpm. Resin columns were assembled and 2,5 ml of Buffer EQ (from the 
kit) were added to the columns in order to equilibrate them. The flow through was 
discarded and once the columns were equilibrated, the supernatant was transferred to 
the columns. The solution was allowed to pass through the resin by gravity and once all 
the liquid had pass, the column was washed with 10ml of DNA wash buffer and the 
flow through discarded. The columns were transferred to fresh tubes and 5 ml of Elution 
buffer (provided in the kit) were added to release pDNA from the resin. Columns were 
discarded and 3,5 ml of isopropanol were added to the flow through. Solution was 
mixed and centrifuged for 30 min at 4300 rpm at 4ºC. Supernatant was discarded, 10 ml 
of 70% ethanol were added to wash the pellet and the tubes centrifuged for 5 min at 4ºC 
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at 4300 rpm. Supernatant was discarded and pellet allowed to dry at room temperature 
until no ethanol drops were visible. Plasmid DNA was resuspended in miliQ water, 
quantified with the Nanodrop and stored at -20ºC until further use. 
 
3.2.2.7 pDNA digestion 
 
One of the steps prior to the synthesis of the in-situ probes is the linearization of the 
pDNA. Linearization will result in a site for the synthesis to end, as no stop codon is 
present in the pDNA. For this reason, enzymes were chosen with three criteria present: 
(1) cleave the construct only once, (2) cleave only in the MCS and (3) restrict the 
cleaving site to one of the insert flanks so that the cRNA would have the correct 
orientation (to pair with the mRNA expressed in the cells). Fragment orientation was 
determined by blasting the sequencing data against a data base (that confirmed that the 
gene Susd4 had not been cloned, and was not considered from this step forward). 
Linearization of the vectors with fragments for Id2, Rik, Notch2, Zfp36, and Shh  were 
previously prepared by a member of the laboratory. 
Digestion reaction mix was as described in table 3.5. 
Table 3. 5: Reaction mix for the restriction digestion of the pDNA for different genes. Digestion 
reactions were carried out with 10 mg of pDNA except for those marked with * (maximum amount of 
pDNA for the reaction volume of 100l were the values presented; x corresponds to the volume of water 
needed to make 100l of total volume; restriction enzymes, buffer and BSA from New England Biolabs).   
 Muc4 Dusp1 Igfbp5 Btg2 Ascl2 Ngn3 
Buffer 10X 10 10 10 10 10 10 
BSA 100X 1 1 1 1 1 1 
Enzyme NdeI NotI NcoI-HF NotI NcoI-HF NcoI-HF 
Enzyme volume 4 4 4 4 4 4 
DNA 10 g 10 g 10 g 6 g* 10 g 4,9 g* 
Water x x x - x - 
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Tubes were spin down and incubated at 37ºC for 4 hours, after which a 
phenol:chloroform  purification was performed. With this process restriction enzymes 
were removed from the solution retrieving the linearized pDNA with a high purity. 
Removal of the enzymes was possible due to the fact that phenol and chloroform 
denaturate proteins. Proteins then fall into the interphase between the organic and 
aqueous phases. By retrieving the aqueous phase, the nucleic acids are collected. 
To carry out the phenol:chloroform purification, 200 l of water were added, as well as 
30 l of NaCl 5 M and 300 l of UltraPure Phenol:Chloroform:Isoamyl Alcohol 
(Invitrogen, Germany). Mix was gently vortexed and centrifuged for 2 min and room 
temperature at 13000 rpm. Upper phase was transferred to a fresh tube, 200 l of 
chloroform (Carl Roth GmbH, Germany) were added and the mix was gently vortex and 
centrifuged for 2 min and room temperature at 13000 rpm. Upper phase was collected 
and 2.5V of 100% ethanol (Carl Roth GmbH, Germany) were added. Mix was vortexed 
and centrifuged for 25 min at 4ºC at 13000 rpm. Supernatant was removed and the 
pellets washed with ethanol 70%, centrifuged for 1 min at 13000 rpm at 4ºC. 
Supernatant was discarded and pellets allowed to dry at room temperature. When the 
ethanol was all evaporated, pellets were resuspended in 20 l of miliQ water and 
quantified in Nanodrop.  
Samples were stored at -20ºC until used for the synthesis of the RNA probes. 
 
3.2.2.8 Reverse transcription and probe purification 
 
Determination of the fragment orientation prior to linearization is important to make 
sure that the antisense strand of the insert will be synthesized. Otherwise the probe will 
not hybridize with the mRNA in the tissue and the in situ will not be successful.  
The linearized plasmids and purified as described in the previous section were used to 
generate antisense DIG-labeled RNA-probes. They were generated with T7 RNA 
polymerase (Promega, Germany), if insert orientation was 3’→5’ in the vector, or SP6 
RNA polymerase (Promega, Germany), if the fragment presented the opposite 
orientation. 
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The synthesis of RNA labeled probes was as described in table 3.6. 
 
Table 3. 6: Reaction mix for the synthesis of RNA DIG-labeled probes for ISH of slides. Synthesis of the 
RNA probes was carried out with T7 RNA polymerase or SP6 RNA polymerase, according to the 
fragment orientation. Probes were labeled with DIG using DIG labeling mix (Roche, Germany) and 
RNase Out (Invitrogen, Germany) to inhibit RNases activity.   
Components Volume (l) 
5X Transcription Buffer 4 
DIG-labeling mix 2 
Linearized pDNA 1 
DTT (100 mM) 2 
RNA Polymerase (T7/SP6) 2 
RNase Out 0.5 
Water 8.5 
  
Mix was incubated for 2 hours at 37ºC. Once the synthesis was finished, 30 l of miliQ 
water was added to each sample, and the probes purified using Illustra MicroSpin G-50 
Columns (GE Healthcare, Germany), according to the manufacturer’s instruction. 
Briefly, the columns were prepared by resuspending the resin with vortexing, the 
bottom closure was twisted off and the column was placed in the collection tube. 
Assembled tubes were centrifuged for 1 min at 2500 rpm and the flow through 
discarded. Columns were transferred to fresh RNase-free tubes, the mix with the newly 
synthesized probes were loaded into the columns and were centrifuged for 1 min at 
2500 rpm. Flow through was recovered, samples quantified and stored at -80ºC until 
further use. 
 
3.2.2.9 In-situ Hybridization of slides 
 
Sections were rehydrated by an initial immersion for 5 min in Xylol (Carl Roth GmbH, 
Germany) twice, followed by a descending series of ethanol dilutions (twice in 100% 
for 5min, 70%, 50% and 30% for 2 min each) ending with a 5 min wash in PBS 1X. 
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Tissues were fixed with a 15 min immersion in 4% FA (Sigma-Aldrich, Germany) in 
PBS and washed in PBS 1X, twice for 5 min. Once the slides were washed, they were 
placed in a 6% H2O2 (Sigma-Aldrich, Germany) solution for 15 min, followed by 3 
washes in PBS 1X for 2 min each. In order to increase the accessibility of the mRNA to 
the probes, tissues underwent a 10 min digestion with Proteinase K (PeqLab 
Biotechnologie, Germany) (10 g/ml), a 15 min immersion in 4% FA in PBS for 
fixation and 2 washes in PBS 1X for 5 min each. For tissue acetylation, slides were 
immersed for 2 min in 100 mM Tris-HCl, pH 7,5
4
, for 10 min in 0,25% Acetid 
Anhydride (Sigma-Aldrich, Germany) in 100 mM Tris-HCl, pH 7,5 and washed twice 
for 2 min in 2X SSC, pH 5. Tissues were dehydrated with immersion in a increasing 
series of ethanol dilutions (2 min in 30%, 50% and 70% each and twice for 5 min in 
100%). Slides were allowed do dry for approximately 30 min prior to hybridization. 
The hybridization buffer
5
 was pre-warmed to 63ºC. RNA probe (in a final volume of 
10 l) was denaturated at 80ºC for 5-10 min on a ThermoCycler. The denaturated probe 
was added to the hybridization buffer (1l of probe per ml of hybridization buffer). 
Once the hybridization solution was prepared, 100 l were placed on each slide, with 
the borders previously defined using a Wax Pen. Slides with the hybridization solution 
were covered with a cover slip 24x60 mm #1,5 (Gerhard Menzel GmbH, Germany) and 
stored in a humid chamber in the dark at 63ºC overnight. 
Following the incubation at 63ºC the slides were washed, at 60ºC with rocking, twice 
for 15 min in 2X SSC
6
 in 50% Formamide (Sigma-Aldrich, Germany), twice for 15 min 
with 1X SSC and for 30 min with 0,2X SSC. Two final washes were performed with 
TBS at room temperature, 5 min each, followed by an incubation for 60 min with the 
Blocking Solution
7
 in the humid chamber at room temperature. Antibody binding with 
Anti-DIG-AP, Fab fragments (Roche Diagnostics GmbH, Germany) (1:3000) occurred 
overnight at 4ºC in the humid chamber. 
Following antibody binding, the slides underwent 6 washes of 30 min with TBSX
8
 and 
2 washes of 10 min with NTMT
9
, all at room temperature with rocking. This was 
                                                          
4
 Vide Annex for composition of Tris-HCl 
5
 Vide Annex for Hybridization Buffer composition 
6
 Vide Annex for SSC composition 
7
 Vide Annex for Blocking solution composition 
8
 Vide Annex for TBSX composition 
9
 Vide Annex for NTMT composition 
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followed by the staining step where 700 l of staining solution10 was added to each slide 
and incubated at room temperature in the dark in a humid chamber until color developed. 
Staining reactions were terminated by immersing the slides in PBS 1X. 
After staining, the tissues on the slides were dehydrated through an increasing series of 
ethanol (30%, 50%, 70% and 100% twice) 3 minutes each. Slides were transferred to 
Xylol (twice, 5 minutes each). Sections were mounted with Roti-Mount (Carl Roth 
GmbH, Germany) for permanent preparation and allowed to dry O/N under the fume 
cupboard. Slides were observed and photographed under the light microscope Leica 
DM2500. 
 
3.3  Isolation of intestinal cells 
 
This study focus on the changes in gene expression in the ISC and the possible 
mechanisms involved in the expression control. To be able to do so, it was required to 
isolate cell population of interest from all the different cells present in the tissue. This 
was performed by releasing cells from the tissue matrix into a cell suspension. Cells 
from the target population were isolated by FACS through specific markers used for cell 
determination. 
The next sections will describe the methods through which samples were prepared for 
FACS. 
 
3.3.1 Isolation of adult ISC 
 
Adult stem cells were isolated from males of the Lgr5-EGFP-ires-creERT2 strain. This 
strain is a plus for this project as it takes advantage of the fact that adult ISC express the 
protein Lgr5. Through genetic manipulation, this strain expresses EGFP under the Lgr5 
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 Vide Annex for Staining solution composition 
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promoter, thus making it easier to isolate these cells from all the cells found in the small 
intestine. 
After the small intestine was isolated, washed and sectioned as described in section 3.1, 
the fragments were transferred into a 50 ml Falcon. Tissue sections were washed with 
PBS 1X by inversion, until the solution was not cloudy. Solution was removed and 
fresh PBS 1X was added, supplemented with 5 mM EDTA. Tissue was incubated for 5 
min at room temperature in a Table-shaker see-saw rocker SSL4 (Stuart Scientific, GB) 
at 40 rpm. After incubation the solution was mixed with gentle inversion. Solution was 
observed under the binocular for the presence of villus and/or crypts. Solutions rich in 
villus debries were discarded and washes were repeated with fresh PBS 1X/5 mM 
EDTA until the supernatant was poor in villus debris and begined to to be enriched in 
crypts. At this moment, aproximately 25 ml of PBS 1X were added to the tissue sections 
and the mix was shaked vigurously (≈ 10 harsh inversions). Supernatant was collected 
to a fresh tube and washes and supernatant recovery were repeated until no more crypts 
were present in the supernatant. Solutions contaning the crypts were centrifuged at 200g 
for 3 min and at 4ºC. Supernatant was discarded, pellet resuspended in 10 ml of PBS 1X 
and centrifuged again at 200g for 3 min and at 4ºC. Supernatant was removed, pellet 
resuspended in 10ml PBS 1X and transferred to a fresh tube. To dissosiate the cells 
making up the crypts, solution was digested with 2 l dispase (100 mg/ml) (Sigma 
Aldrich, Germany) and 10 l collagenase (50 mg/ml) at 37ºC for 30 min. During 
incubation, the suspension was pipeted to disolve any smeary clouds. Cells were 
observed for single events in a Cell counting device (Neubauer improved) (Carl Roth 
GmbH & Co., Germany). Cell suspension was centrifuged at 200g for 3 min. 
Supernatant was removed, pellet was resuspended in 1ml PBS 1X/2,5 mM EDTA and 
the suspension was rinse through a 30 m Cell strainer cap into a 5 ml tube (BD 
Biosciences, Germany). 
 
Cell suspensions were taken to the IMB cytometry facilities for cell sorting. 
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3.3.2 Isolation of embryonic ISC 
 
After the embryos were isolated, as described in section 3.1, they were dissected under a 
Leica M80 to isolate the small intestine for further processing. The small intestines 
(pooled from several embryos due to the small size, thus low amount of cells) were 
placed in a tube with 500 l of PBS 1X and digested with 5 l of collagenase (50mg/ml) 
and incubated at 37ºC for approximately 15 min on a Thermomixer compact (Eppendorf 
AG, Germany), 800 rpm. During incubation the suspension was pipetted do dissolve 
smeary clouds. Cells were observed for single events in a Cell counting device and PBS 
1X was added up to 1 ml. Cells were centrifuged at 2500 rpm, for 3 min at 4ºC. 
Supernatant was removed and pellet resuspended in 1 ml of PBS 1X and cells were 
centrifuged again at 2500 rpm, for 3 min at 4ºC. Supernatant was discarded and pellet 
resuspended in 100 l of 2% Fetal Bovine Serum (FBS) (PAA Laboratories, Germany). 
To the cell suspension the following antibodies were added: 2,5 l anti-CD31 (BD 
Biosciences, Germany) and 2,5 l anti-EpCAM-PerCP-e710 (eBioscience, Germany) to 
ISC isolation of stage e12.5. For the isolation of ISC from stage e14.5, 2,5 l anti-
CD45-PE (BD Biosciences, Germany) were added together with EpCAM and CD31 as 
previously described.  Cell suspension was resuspended with a pipette every 15 min and 
incubated in the dark for 30 min, at 4ºC. After incubation 900 l of PBS 1X were added 
and centrifuged at 2500 rpm for 3 min at 4ºC. Washing was repetead and cells were 
resuspended in 500 l PBS 1X/2.5mM EDTA. Cell suspension was rinsed through a 30 
m Cell strainer cap into a 5 ml tube prior to be taken to IMB cytometry facilities for 
cell sorting. 
 
3.3.3 Isolation of adult enterocytes 
 
Following small intestine isolation, washing and sectioning as described in section 3.1, 
sections were transferred into a 50 ml Falcon. Tissue was washed with PBS 1X by 
inversion, repeated until the solution was not cloudy. New washes were carried out with 
fresh PBS 1X supplemented with 5 mM EDTA. Tissue was incubated in for 5 min at 
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room temperature in a Table-shaker see-saw rocker SSL4 at 40 rpm. Solution was 
mixed by gentle inversion and observed under the binocular for the presence of villus 
and/or crypts. Solution rich in villus debries weas collected into a fresh 50 ml falcon 
tube and washes were repeated with fresh PBS 1X/5 mM EDTA until the supernatant 
was poor in villus debris. Villi were centrifuged for 3 min, 200g at room temperature. 
Supernatant was discarded and pellet resuspended in 20 ml of PBS 1X. Samples were 
centrifuged again for 3 min, 200g at room temperature. Supernantant was removed and 
pellet resuspended in 4,5 ml of PBS 1X. Villi suspention was distributed into fresh 
eppendorf tubes - 1 ml per tube and 0,5ml for negative control. To prepare cell 
suspention, samples and negative control were digested with 20 g dispase and 50 g 
collagenase. Digestion was incubated for 5 min at 37ºC. Cell suspension was 
centrifuged for 3 min at 2500 rpm, 4ºC. Supernatant was removed and pellet 
resuspended in 1 ml and 200 l of PBS 1X, samples and negative control respectively  
and wash was repeated. Negative control was stored in ice until needed. Samples were 
resuspended in 200 l of 2% FBS. The following antibodies were added: 2.5 l 
anti-CD31, 2.5l 45-PE and 2.5 l anti-EpCAM-PerCP-e710. Cell suspension was 
resuspended with a pipette every 15 min and incubated in the dark for 30 min, at 4ºC.  
Following incubation, 900 l of PBS 1X were added and centrifuged at 2500 rpm for 3 
min at 4ºC. Washing was repetead and cells were resuspended in 500 l PBS 
1X/2.5mM EDTA. Cell suspension was rinsed through a 30 m Cell strainer cap into a 
5 ml tube prior to be taken to IMB cytometry facilities for cell sorting. 
 
3.4  MBD-seq 
 
MBD-seq is a widely technique to study methylation patterns of DNA. This is possible 
through the use of the proteins of the MBD family. As this proteins have the ability to 
bind specifically to the methylated cytosines in the DNA, they can isolate DNA 
fragments that are methylated from the remaining residue. 
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This experiment was carried out by a member of the Epigenetic Regulation of 
Transcription in Mouse Development and Disease group using the MethylMiner™ 
Methylated DNA enrichment kit (Invitrogen, Germany) according to the manufacturer’s 
instructions. Samples used were ISC isolated by FACS as described in sections 3.3.1 
and 3.3.2 for  adult and embryo (e12.5) cells, respectively. 
 
3.5  Bisulfite sequencing 
 
One strategy to determine the methylation pattern of a given DNA sequence is the use 
of sodium bisulfate. DNA treatment with sodium bisulfate will deaminate unmethylated 
cytosine residues into Uracil (U), leaving the remaining C untouched. Thus, this 
treatment will give rise to different DNA sequences according to the methylation states 
of such sequences. 
In order to validate the data from MBD-seq and have a more precise image of the 
methylation pattern, a few genes were chosen to undergo this treatment. The genes that 
were chosed were selected based on the MBD-seq data from adult and e12.5 ISC, in 
order for the genes to fall into the following groups: unmethylated in both stages, 
methylated in adult and unmethylated in embryo, methylated at e12.5 and unmethylated 
in adult, and methylated in both stages. 
With the information about methylation in 2 distinct development stages already known, 
and to be confirmed by bisulfite sequencing, this was considered and opportunity to 
gather information about possible changes during development. Thus, samples used in 
this techique were ISC at stages e12.5, e14.5 and adult ISC and also adult enterocytes 
(AE), 3 replicates per stage. 
 
The genes that were selected for this study were those described in table 3.7 
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Table 3. 7: Genes selected for methylation pattern analysis with sodium bisulfite. Genes were selected 
according to their methylation status in both staged analyzed, based on the data from the MBD-seq 
(section 3.4) 
  Adult 
  Unmethylated Methylated 
E
1
2
.5
 
Unmethylated 
Ndufaf3 
Id2 
Foxa1 
Nrp2 
Shh 
Fzd2 
Meis 1 
Grb10 
Mdk 
Methylated 
Olfm4 
Elf3 
Vdr 
Ephb3 
Oct4 
Lgr5 
Efnb2 
  
Bisulfite sequencing included gDNA extraction and purification, sodium bisulfate 
treatment with the Epitect® Bisulfite kit (Qiagen, Germany), amplification of target 
fragments and purification. 
 
3.5.1 Extraction and purification of gDNA 
 
Genomic DNA was isolated from sorted ISC from stages e12.5, e14.5, adult and AE, as 
described in sections 3.3.1, 3.3.2 and 3.3.3, respectively. 
Extraction of gDNA was carried out as follows. To each tube were added 5M NaCl, 
0.5M EDTA, 0.5M Tris pH8 and SDS 10% to the final concentrations of 100mM, 
10mM, 100mM and 0.1%, respectively. Samples were sonicated twice for 20 sec, with 
90 sec pause, at high power and then treated with 1:1000 RNase A (Qiagen, Germany). 
For RNA digestion, samples were incubated for 30 min at 37ºC. This was followed by 
Proteinase K digestion for 5 hours at 55ºC. The DNA was now released from the cells 
and found in a mix of nucleic acids and cell debris. Purification of gDNA was carried 
out by phenol:chlorophorm precipitation. Briefly, 0.1V of 5M NaCl and 1V of 
UltraPure Phenol:Chloroform:Isoamyl Alcohol were added to the tubes. Mix was gently 
vortexed and centrifuged for 2 min and room temperature at 13000 rpm. Upper phase 
was collected to a fresh tube, 1V of chloroform was added and the mix was gently 
vortex and centrifuged for 2 min and room temperature at 13000 rpm. Upper phase was 
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collected and 2.5V of 100% ethanol were added. Mix was vortexed and centrifuged for 
25 min at 4ºC at 13000 rpm. Supernatant was removed and the pellets washed with 
ethanol 70%, centrifuged for 1 min at 13000 rpm at 4ºC. Supernatant was discarded and 
pellets allowed to dry at room temperature. When the ethanol was all evaporated, pellets 
were resuspended in 25 l of RNase-free water. Samples were quantified with 
Nanodrop and stored at -20ºC until needed. 
 
 
3.5.2 Sodium Bisulfite treatment  
 
Conversion of gDNA unmethylated C to U, was carried out with sodium bisulfite 
treatment using the Epitect
®
 Bisulfite kit (Qiagen, Germany) according to the 
manufacturer’s instructions.  
To carry out this experiment, 1 g of extracted and purified gDNA of each sample was 
used. DNA was thawed and the reaction mix was prepared as described in table 3.8. 
 
Table 3. 8: Reaction mix for the sodium bisulfite treatment of gDNA from the Epitec® Bisulfite kit. 
Bisulfite Mix and DNA protect buffer were provided in the kit. * Combined volume of DNA and water 
should not be over 20 l. 
Component Volume per reaction (l) 
DNA solution 1 g (maximum 20 l) 
Water Variable* 
Bisulfite Mix 85 
DNA protect Buffer 35 
Total volume 140 
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Following the preparation of the reaction mixes, they were vortex thoroughly to ensure 
that the solutions were homogeneous. Bisulfite conversion was carried out in a thermal 
cycler and programed according to table 3.9. 
 
Table 3. 9: Thermal cycler conditions, temperatures and step durations, for the bisulfite conversion using 
the Epitec® Bisulfite kit, for a final reaction volume of 140 l. 
Step Duration (min) Temperature (ºC) 
Denaturation 5 95 
Incubation 25 60 
Denaturation 5 95 
Incubation 85 60 
Denaturation 5 95 
Incubation 175 60 
Hold Indefinite 20 
 
 
Once the bisulfide conversion was completed, products underwent a series of cleanup 
steps. Following the reaction in the thermal cycler, samples were centrifuged and 
transferred to clean 1.5 ml microcentrifuge tubes. To each reaction mixture 560 l of 
freshly prepared Buffer BL (provided in the kit) were added. Solution was vortex and 
spined down. The mixture was tranferred into the previously prepared columns. 
Columns and collection tubes were centrifuged for 1 min, maximum speed at room 
temperature. The supernatant was discarded and the columns placed back in the 
collection tudes. To each column 500 l of Buffer BW were added. Columns were 
centrifuged for 1 min, maximum speed at room temperature, flow-through discarded 
and 500 l of Buffer BD were added. Columns were incubated with Buffer BD for 15 
min at room temperature and centrifuged for 1 min, maximum speed at room 
temperature. Flow-through was discaded and DNA bound to the column was washed 
twice by adding 500 l of Buffer BW, centrifuging (1 min, maximum speed) and 
discarding the flow-through. Columns were transferred to freshcollection tubes and 
spined down to remove residual liquid. The spin columns were placed in fresh 1.5 ml 
microcentrifuge tubes and 20 l of Buffer EB were added onto the center of the 
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membrane. Purified DNA was eluted with a 1 min centrifugation at maximum speed 
and room temperature. 
Samples were stored at -20ºC until needed. 
 
3.5.3 Target amplification 
 
With the approach taken for the analisys of the methylation pattern, through bisulfite 
sequencing, it was necessary to focus in a few regions of the gDNA. In order to to so, 
specific primers were designed to amplify fragments of the genes selected for analysis 
(table 3.7).  
 
3.5.3.1 Primer design 
 
Primers were designed using MethPrimer online software (www.urogene.org/cgi-
bin/methprimer/methprimer.cgi) that predicts the sequence after citosine conversion by 
sodium bisulfite treatment and present several options of specific primers that can be 
used for PCR. 
General parameters for primer design used were as default with the exception of the 
fragment size that ranged from 300 to 500 bp, with 400 bp being set as optimal 
fragment size. These sizes were defined according to the limitations of sequencing 
analysis. 
 
Primers designed were those presented on table 3.10. 
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Table 3. 10: Primer sequences of the specific primers for amplification of gene fragments of the selected 
genes for analysis of methylation pattern and expected size of amplicon (bp). Primers were designed with 
MethPrimer for amplicon size 400 ± 100 bp. 
Gene Primer sequences (5’→3’) Amplicon size (bp) 
Ndufaf3 Fw GGTTGGATAGGGGATGTTTATTATAG 468 
Rv CACACCCTAACCAAATATTCATAAC 
Id2 Fw TAAATGTTTGTAAAAGATTGGGAGAG 329 
Rv CCCCTATACTCTAAAATCCAAATTTC 
Foxa1 Fw GTTTAGAGTTTGGGGGTTGG 401 
Rv AAATCATAAACCTCTTCCCCTATTAC 
Nrp2 Fw GGGTTGAAGTTGGTGAAGTAAGTTA 379 
Rv AAAACAATCCCAAAATAAAAAAACC 
Shh Fw GGAAGGGATGTAGTAATAATAGGTT 481 
Rv ACTCTAAAACACCAAATACCAATTC 
Fzd2 Fw TTAAAAGTTGTTTTGTGTTTTGGTT 409 
Rv ATAAAAAATAAAAACCATTCCTCCC 
Meis1 Fw ATTTTTGATGTTAATTGGTTGTTTG 371 
Rv CTTAATAAAAATAACCCCTCACTCC 
Grb10 Fw TTTTGGTTTTTAGATTTGTGAAATG 314 
Rv CTCCCAAAAATAAATCTTACCTACC 
Mdk Fw TTTTAGGGGTAAAATTTGGGTTAG 327 
Rv TTCTAAAAACAAAAAAAACCTTAAC 
Olfm4 Fw GTGTGTATGAGAAGAGGTTTTTGAAT 306 
Rv AACCAACTAACCTTAAACACACAAA 
Elf3 Fw TTGAGTTTATTAGAAGAGTTGGAGGTT 429 
Rv ACAAAATCCCAAAAAAACAAAACTA 
Ephb3 Fw TGGTTTTTTAGGATTAAGGTGTTTG 445 
Rv TCTCTCCCATATCCCTCTTTATAAAA 
Vdr Fw GTTTGTTTGTTTGTTTGTTTGTTTG 445 
Rv CTTACCCTAATTACCAAAACCCTCT 
Oct4 Fw GTTGTGAGTTATTTTGTGGTTGTTG 423 
Rv AATACCCCAACAAATTCCTATCTACT 
Lgr5 Fw GGGGAGGGAAGATAGATAGATAGATAG 401 
Rv CCCCAAAACAAAAATTCTAAAATTAC 
Efbn2 Fw TGTTTGTAGTTTTTAGTGGTATGATAA 413 
Rv CTCCTTTACCCTATCTATCAAATTC 
 
 
Primers were resuspended according to the manufacturer’s (Sigma-Aldrich, Germany) 
intructions for a final concentration of 100 M using miliQ water. 
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3.5.3.2 PCR conditions 
 
Conditions for the PCR reactions were optimized in order to set the best temperature of 
annealing (Ta) and the concentration of magnesium cloride (MgCl2) for each pair of 
primers. 
The choice of Ta is largely determined by the melting temperature of the pair of primers, 
estimated by the software. As the behaviour of new primers during a PCR reaction is 
not well known, they were tested in a gradient of temperatures, starting at a lower 
temperature – less specific – up to a higher temperature – more specific, thus reducing 
the probability of secondary products. In respect to the concentration of MgCl2, it was 
tested simultaneously with the temperature gradiente using also highly stringent 
conditions, with 1.5 mM MgCl2 as well as a more permissive concentration – 2 mM. 
This optimization was also an opportunity to assess the primers that were design and 
establish those that were able to produce an amplicon. 
In order to reduce the risk of misreading of the polymerase enzyme during the PCR 
reaction, thus leading to incorrect data, a high fidelity system, AccuPrime™ Taq DNA 
Polymerase System (Invitrogen, Germany), was used. 
After optimization, the best conditions for amplifing the different gene fragments, in 
respect to MgCl2 concentrations were as presented on table 3.11. 
 
Table 3. 11: Conditions, in respect to MgCl2 concentrations, to be used for amplification of the different 
genes. 
 Low MgCl2 (1.5 mM) High MgCl2 (2mM) 
G
en
es
 
Ephb3 Elf3 
Ndufaf3 Grb10 
Fzd2 Id2 
Lgr5 Vdr 
Oct4  
Olfm4  
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Thus, the final conditions for PCR mix with the different MgCl2 concentrations are 
presented on table 3.12. 
 
Table 3. 12: PCR reaction mix for amplification of gene fragments in MgCl2 stringent and less stringent 
conditions (1.5 mM and 2 mM of MgCl2, respectively) for a final volume of 50 l.  
 Low MgCl2 (1.5 mM) High MgCl2 (2mM) 
Component Volume (l) Volume (l) 
10X AccuPrime PCR Buffer II 5 5 
Primer Mix (1M) 10 10 
AccuPrime™ Taq DNA Polymerase 0.85 0.85 
DNA converted (1:5) 2 2 
MgCl2 (50 mM) --- 1.25 
Water RNase-free 32.15 30.90 
Total volume 50 50 
 
 
During optimization, the Ta for each pair of primers were also determined. They were 
as presented in table 3.13. 
 
Table 3. 13: Temperatures of annealing (Ta) for the amplification of the fragments of the different genes 
by PCR reactions. 
Temperatures 52ºC 55ºC 56ºC 60ºC 
G
en
es
 
Ephb3 Fzd2 Lgr5 Vdr 
Ndufaf3 Elf3 Oct4  
 Grb10 Olfm4  
  Id2  
 
 
Amplification reactions by PCR were carried out in a thermo cycler as follows (table 
3.14). 
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Table 3. 14: Cycling conditions for the PCR reactions for amplification of fragments of the different 
target genes after sodium bisulfate treatment. Ta specific for each pair of primers are presented on table 
3.13. 
Temperature (ºC) Duration Number of cycles 
95 5 min  
95 35 sec 4 cycles 
(with Ta decreasing 
1ºC per cycle) 
Ta+4 30 sec 
68 50 sec 
95 35 sec 
37 cycles Ta 30 sec 
68 50 sec 
68 7 min  
4 4 min  
 
Reaction products were analysed by electrophoresis in a 1.5% agarose gel stained with 
ethidium bromide. To 10 l of PCR products, 2 l of 6X Orange DNA Loading Dye 
(Fermentas) were added, and the final volume was loadded into the gel for amplicon 
visualization. This was carried out in a Chemidoc XRS system (Biorad, Germany). 
 
When required, reamplification was performed under the same conditions as described 
in tables 3.12 and 3.14, using as template the PCR products from the first reaction. 
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4. Results 
 
Throughout this study two main approaches were taken: morphological and molecular. 
The morphological techniques were used to identify the location where a given gene 
was expressed in the tissue of interest – small intestine in different developmental stages. 
With the molecular approach, it was aimed to validate and acquire a more detailed 
perspective of the changes in the methylation patterns identified by MBD-seq. 
 
4.1  Sampling 
 
The study of gene expression throughout the development of the small intestine in mice 
required the collection of adult small intestine and mouse embryos at different 
developmental stages. In Fig 4.1 mouse embryos at stages e12.5 and e14.5 (images A 
and B, respectively) as well as a small portion of adult small intestine (image C) rich in 
villus, are presented. 
 
 
Fig 4. 1: Mouse embryos at developmental stages e12.5 (A) and e14.5 (B) and small section of adult 
small intestine (C).  
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4.2  In-situ hybridization 
 
To gaininformation about the specific location of a given set of genes, the ISH 
technique was used. By targeting a gene’s mRNA with complementary probes it was 
possible to locate where the target gene was expressed. Target genes were selected 
based in data from RNA-seq previously prepared of ISC from e12.5 and adult. Through 
this process an accurate estimation of transcript abundance was mapped
75
 producing  
genome-wide transcriptional maps, in this case, of the ISCs at e12.5 and adult stages. 
Expression levels were determined by initially converting the isolated RNA into a 
cDNA library. Then, the reads were mapped against the mouse genome as reference, 
followed by counting the number of reads that aligned to the DNA sequence. 
Comparing which genes were expressed at the ISC in stage e12.5 and adult, was 
possible to observe that the genes expressed in mouse ISCs are different between the 
two developmental stages 
In order to carry out the ISH on slides, several intermediate steps were carried out in 
order to prepare the probes and to ensure they were in the best conditions. 
 
4.2.1 Fragment amplification for RNA probe preparation 
To assess the success of the amplification reaction for the Ngn3 gene, 10 l of loading 
buffer were added to the reaction volume and the total volume was loaded into a 1.5% 
agarose gel in 1X TAE, stained with EtBr (Fig 4.2). 
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Fig 4. 2: Products of PCR reaction for the amplification of a fragment of Ngn3 on a 1.5% agarose gel in 
1X TAE, stained with EtBr. Lanes 1 to 4 are different PCR products, specific for Ngn3, lane L is the 
DNA ladder Gene Ruler 1Kb Plus DNA and lane C- is the negative control for the PCR reaction. 
(Samples run from the highest to the lowest molecular weight). 
 
The PCR reaction performed for the amplification of a Ngn3 fragment appeared to be 
specific. The PCR reactions produced one single band with the a size higher than 
500 bp (expected sized of the fragment was 608 bp). 
Contaminations were discarded as the negative control was clear. 
PCR products were then processed (purified and cloned) to determine fragment’s 
identity. This was achieved by sequencing at the GATC Biotech facilities, which 
confirmed that the cloned fragment was Ngn3. Following identity confirmation, a larger 
amount of pDNA was required and prepared. The pDNA was then linearized for further 
use in reverse transcription of the cRNA probes. 
 
4.2.2 Reverse transcription 
 
Once the reverse transcription was finished and the probes purified, they were loaded 
onto an agarose gel to assess the success of the reaction. Probes that had been 
previously prepared and were stored were also loaded into an agarose gel. This allowed 
to check for any signs of probe deterioration.  
Probes were loaded into different gels. In the first gel cRNA probes for Ascl2, Muc4, 
Igfbp5, Btg2 and Dusp1 were loaded (Fig 4.3). 
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Fig 4. 3: Probes for the ISH method (5 l of each probe) in a 1.5% agarose gel in 1X TAE, stained with 
EtBr. cRNA probes DIG-labeled were Ascl2 (lane 1), Muc4 (lane 2), Igfbp5 (lane 3), Btg2 (lane 4) and 
Dusp1 (lane 5). Lane L is the ladder Gene Ruler 1Kb Plus DNA. (Samples run from the highest to the 
lowest molecular weight). 
 
From the observation of the gel, it was confirmed that the probes for Ascl2, Muc4, 
Igfbp5, Btg2 and Dusp1 were in good conditions and were used downstream in the ISH 
protocol.  
Following the reverse transcription to prepare the probe for Nocht2, 5 l of probe, 
DIG-labeled were loaded onto a 1% agarose gel in 1X TAE stained with EtBr (Fig 4.4) 
for quality analysis. 
 
 
Fig 4. 4: Notch2 probe, DIG-labeled, with 5 l of Orange DNA Loading dye in a 1% agarose gel stained 
with EtBr. Lane L is the ladder Gene Ruler 1Kb Plus DNA and lane 1 is the probe for Notch2. (Samples 
run from the highest to the lowest molecular weight). 
 
 
58 
Analyzing the gel from the electrophoresis on the cRNA probes for Notch2 (Fig 4.4) it 
was confirmed also that the probe was in good conditions and could be used for ISH on 
slides. The low sharpness of the bands was due to the low percentage of agarose. 
The probe for Ngn3 was analyzed by electrophoresis by loading 5 l of probe, 
DIG-labeled, onto a 1% agarose gel in 1X TAE stained with EtBr (Fig 4.5) for quality 
analysis. 
 
 
Fig 4. 5: Ngn3 probe, DIG-labeled, with 5 l of Orange DNA Loading dye in a 1.5% agarose gel stained 
with EtBr. Lane L is the ladder Gene Ruler 1Kb Plus DNA and lane 1 is the probe for Notch2. (Samples 
run from the highest to the lowest molecular weight). 
 
The Neurogenin3 (Ngn3) probe was also in proper conditions to be used in the ISH of 
slides. The faint smear on the gel (Fig 4.5) was due to a low concentration of probe and 
also to the low percentage of agarose of the gel. 
 
4.2.3 ISH on slides 
 
This task of the current study was performed in order to validate the RNA-seq data. It 
was also an opportunity to gather information about the changes in the gene’s 
expression during the embryonic development. Thus gene expression was also analyzed 
in stages e13.5, e14.5 and e15.5. 
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Genes analysed include Ascl2 (Fig 4.6), Btg2 (Fig 4.7), Cps1 (Fig 4.8), Dusp1 (Fig 4.9), 
Hes1 (Fig 4.10), Igfbp5 (Fig 4.11), Kcne3 (Fig 4.12), Muc4 (Fig 4.13), Notch2 
(Fig 4.14), Shh (Fig 4.15) and Ngn3 (Fig 4.16). 
 
 
Fig 4. 6: Expression pattern of the gene Ascl2 resulting from RNA-seq (A) and ISH (B to F). Data from 
RNA-seq (A) show the expression pattern between mouse e12.5 and adult ISC. ISH specific for the gene 
Ascl2 in fixed sections of mouse embryos e12.5 (B), e13.5 (C), e14.5 (D) and e15.5 (E) and adult mouse 
small intestine (F). Note the different structures present in the sections throughout the developmental 
stages, l – lumen, e - endothelium, m – mesenchyme, iv – intravillus region, v – villi, c – crypt. Scale bar 
corresponds to 50m. 
 
In respect to the results on the expression of Ascl2 (Fig 4.6), it was noticed a higher 
expression on the adult ISC (Fig 4.6 A). Regarding the ISH targeting Ascl2 on sections 
of small intestine (Fig 4.6 B to F), no expression was detected in the sections from 
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embryos (Fig 4.6 B to E), since there are no regions with higher intensity of staining. In 
the sections of the adult small intestine (Fig 4.6 F) it appears that some regions of the 
crypts present a slight more intense staining. 
 
 
Fig 4. 7: Expression pattern of the gene Btg2 resulting from RNA-seq (A) and ISH (B to F). Data from 
RNA-seq (A) show the expression pattern between mouse e12.5 and adult ISC. ISH specific for the gene 
Btg2 in fixed sections of mouse embryos e12.5 (B), e13.5 (C), e14.5 (D) and e15.5 (E) and adult mouse 
small intestine (F). Note the different structures present in the sections throughout the developmental 
stages, l – lumen, e - endothelium, m – mesenchyme, iv – intravillus region, v – villi, c – crypt. Scale bar 
corresponds to 50m. 
 
From the RNA-seq data for the gene Btg2 (Fig 4.7 A) the expression of this gene is 
stronger in the adult ISCs when compared with the expression levels detected for the 
embryonic ISCs that were isolated. In the ISH study of the gene Btg2 (Fig 4.7 B to E) 
no increase in staining is detected. The absence of staining intensity in the sections from 
e12.5 (Fig 4.7 B) are in accordance with the data from the RNA-seq data. Nevertheless, 
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the staining in the sections from the adult tissue (Fig 4.7 F) show a stronger staining in 
the epidermal layer when compared with the underlying tissues of the small intestine. 
 
 
Fig 4. 8: Expression pattern of the gene Cps1 resulting from RNA-seq (A) and ISH (B to F). Data from 
RNA-seq (A) show the expression pattern between mouse e12.5 and adult ISC. ISH specific for the gene 
Cps1 in fixed sections of mouse embryos e12.5 (B), e13.5 (C), e14.5 (D) and e15.5 (E) and adult mouse 
small intestine (F). Note the different structures present in the sections throughout the developmental 
stages, l – lumen, e - endothelium, m – mesenchyme, iv – intravillus, v – villi, c – crypt. Scale bar 
corresponds to 50m. 
 
Observing the expression patterns of the gene Cps1 (Fig 4.8), it was perceived, from the 
RNA-seq data (Fig 4.8 A), that this gene had a higher expression in the adult ISC when 
compared with the ISC at stage e12.5. Data from RNA-seq are further supported with 
the ISH results (Fig 4.8 B to F). The results from the ISH method show, on adult small 
intestine (Fig 4.8F) a higher intensity of staining in the crypt. Comparing to the other 
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stages (Fig 4.8 B to E), no increasing on staining intensity is noted. Nevertheless, it is 
possible to note that are some spots in the intestinal endothelium  in the stages e12.5 to 
e14.5 (Fig 4.8 B to D). In the interface between the lumen and the intestinal 
endothelium in the stage e15.5 (Fig 4.8 E) there is a strong unspecific staining not 
related to specific hybridization, but rather caused by the accumulation of pigment. 
 
 
Fig 4. 9: Expression pattern of the gene Dusp1 resulting from RNA-seq (A) and ISH (B to F). Data from 
RNA-seq (A) show the expression pattern between mouse e12.5 and adult ISC. ISH specific for the gene 
Dusp1 in fixed sections of mouse embryos e12.5 (B), e13.5 (C), e14.5 (D) and e15.5 (E) and adult mouse 
small intestine (F). Note the different structures present in the sections throughout the developmental 
stages, l – lumen, e - endothelium, m – mesenchyme, iv – intravillus, v – villi, c – crypt. Scale bar 
corresponds to 50m to all sections except F, where it corresponds to 75m. 
 
Observing the results from the RNA-seq and ISH on the gene Dusp1 (Fig 4.9), some 
differences can be noticed. In respect to the RNA-seq data (Fig 4.9 A), a strong 
expression of the gene was detected in the population of adult ISCs. Nevertheless, a 
very low level of expression of Dusp1 is detected in the embryonic samples from e12.5. 
The ISH (Fig 4.9 B to F), on the other hand, presented with no changes in the 
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expression of the gene (which would be seen as an increase in staining intensity if the 
amount of transcripts were higher) in the stage e12.5 (Fig 4.9 B) although an increase of 
staining intensity could be noticed in the sections of adult tissue (Fig 4.9 F), at the 
bottom of the crypts. Also no changes in the staining were detected in the sections from 
e13.5, e14.5 and e15.5 (Fig 4.9 C, D and E respectively) indicating that this gene is not 
transcribed during embryonic development. 
 
 
Fig 4. 10: Expression pattern of the gene Hes1 resulting from RNA-seq (A) and ISH (B to F). Data from 
RNA-seq (A) show the expression pattern between mouse e12.5 and adult ISC. ISH specific for the gene 
Hes1 in fixed sections of mouse embryos e12.5 (B), e13.5 (C), e14.5 (D) and e15.5 (E) and adult mouse 
small intestine (F). Note the different structures present in the sections throughout the developmental 
stages, l – lumen, e - endothelium, m – mesenchyme, iv – intravillus, v – villi, c – crypt. Scale bar 
corresponds to 50m to all sections except F, where it corresponds to 75m. 
 
The expression analysis of Hes1 in the RNA-seq data (Fig 4.10 A) shows that this gene 
has a higher expression in the cells from the adult small intestine. The ISH sections 
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(Fig 4.10 B to F) confirms that expression pattern. In the section from the 
developmental stage e12.5 (Fig 4.10 B) no staining is detected relative to the target gene. 
As development continues (e13.5, e14.5 and e15.5) an increase in the staining intensity 
can be noticed (Fig 4.10 C to E). The expression of Hes1 continues in the adult small 
intestine (Fig 4.10 F), specifically in the intestinal crypts. This validates the RNA-seq 
data and also shows that expression of the gene Hes1 starts at early embryonic 
development and not only in the adult small intestine.   
 
 
Fig 4. 11: Expression pattern of the gene Igfbp5 resulting from RNA-seq (A) and ISH (B to F). Data from 
RNA-seq (A) show the expression pattern between mouse e12.5 and adult ISC. Note the exon represented 
with the solid box at the bottom. ISH specific for the gene Igfbp5 in fixed sections of mouse embryos 
e12.5 (B), e13.5 (C), e14.5 (D) and e15.5 (E) and adult mouse small intestine (F). Note the different 
structures present in the sections throughout the developmental stages, l – lumen, e - endothelium, m – 
mesenchyme, iv – intravillus, v – villi, c – crypt. Scale bar corresponds to 50m to all sections except F, 
where it corresponds to 75m. 
 
Analysis of the expression of the gene Igfbp5 was performed based on RNA-seq and 
ISH (Fig 4.11). From the RNA-seq (Fig 4.11 A), it can be observed that this gene is 
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expressed only at stage e12.5, as it was in these samples that a higher amount of 
transcripts was detected. The results from the ISH (Fig 4.11 B to F) show no differences 
in the intensity of the staining in the stages e12.5 and the adult ISC (Fig 4.11 B and F, 
respectively). Section from e13.5 show a signal in the endothelium (Fig 4.11 C) which 
may indicate that these gene is not expressed only at stage e12.5 (form RNA-seq data). 
 
 
Fig 4. 12: Expression pattern of the gene Kcne3 resulting from RNA-seq (A) and ISH (B to F). Data from 
RNA-seq (A) show the expression pattern between mouse e12.5 and adult ISC. Note the exon represented 
with the solid box at the bottom. ISH specific for the gene Kcne3 in fixed sections of mouse embryos 
e12.5 (B), e13.5 (C), e14.5 (D) and e15.5 (E) and adult mouse small intestine (F). Note the different 
structures present in the sections throughout the developmental stages, l – lumen, e - endothelium, m – 
mesenchyme, iv – intravillus, v – villi, c – crypt. Scale bar corresponds to 50m to all sections except F, 
where it corresponds to 75m. 
 
The expression analysis of Kcne3 by RNA-seq (Fig 4.12 A) show that this gene is 
highly expressed in the population of adult ISCs isolated. This data also indicate that 
there is some expression in the embryonic endothelial cells (e12.5), although not as 
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strong as the detected in the adults. Staining for the gene Kcne3 shows its expression at 
e12.5 (Fig 4.12 B) spread throughout all endothelium, while in the adult sections (Fig 
4.12 F), gene expression is detected at the bottom of the crypts. Regarding the 
intermediate embryonic stages e13.4, e14.5 and e15.5 (Fig 4.12 C, D and E, 
respectively) gene transcripts were also detected indicating that the gene is present in all 
developmental stages. Note that at stage e15.5 (Fig 4.12 E), the expression is detected in 
more localized region – the intervillus regions that start to appear at this stage. 
 
 
Fig 4. 13: Expression pattern of the gene Muc4 resulting from RNA-seq (A) and ISH (B to E). Data from 
RNA-seq (A) show the expression pattern between mouse e12.5 and adult ISC. Note the exon represented 
with the solid box at the bottom. ISH specific for the gene Muc4 in fixed sections of mouse embryos 
e12.5 (B), e14.5 (C), e15.5 (D) and adult mouse small intestine (E). Note the different structures present 
in the sections throughout the developmental stages, l – lumen, e - endothelium, m – mesenchyme, iv – 
intravillus, v – villi, c – crypt. Scale bar corresponds to 50m to all sections except E, where it 
corresponds to 75m. 
 
The data from the RNA-seq on the gene Muc4 (Fig 4.13 A) gives the indication that this 
gene has a higher expression in the adult ISC in comparison with e12.5. The 
complementary analysis on this gene by ISH (Fig 4.13 B to E) is in accordance with this 
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observation. Focusing on the section from the adult small intestine (Fig 4.13 E), a slight 
increase in the intensity of the staining can be noticed in the cryps. Changes in the 
intensity of the staining on the intestinal endothelium, when compared to the 
surrounding tissues, in the embryonic stages (Fig 4.13 B to D) present no changes. This 
could be indicative that the gene is not expressed at such early stages. 
 
 
Fig 4. 14: Expression pattern of the gene Notch2 resulting from RNA-seq (A) and ISH (B to E). Data 
from RNA-seq (A) show the expression pattern between mouse e12.5 and adult ISC. Note the exon 
represented with the solid boxes at the bottom. ISH specific for the gene Notch2 in fixed sections of 
mouse embryos e13.5 (B), e14.5 (C), e15.5 (D) and adult mouse small intestine (E). Note the different 
structures present in the sections throughout the developmental stages, l – lumen, e - endothelium, m – 
mesenchyme, iv – intravillus, v – villi, c – crypt. Scale bar corresponds to 50m to all sections except E, 
where it corresponds to 75m. 
 
Expression pattern of the gene Notch2 was performed by RNA-seq and ISH (Fig 4.14). 
Data from RNA-seq data (Fig 4.12 A) do not present major differences in the amount of 
transcripts between the ISCs populations from e12.5 and adult mice. Results from ISH 
on Notch2 (Fig 4.12 B to E) present changes in staining intensity in the intestinal 
endothelium. These changes are stronger at stages e14.5 and e15.5 (Fig 4.12 C and D, 
respectively), with slight changes being noticeable at e13.5 (Fig 4.12 B) and at the 
bottom of the crypts in section of the adult small intestine (Fig 4.12 E). 
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Fig 4. 15: Expression pattern of the gene Shh resulting from RNA-seq (A) and ISH (B to E). Data from 
RNA-seq – number of reads (A) show the expression pattern between mouse e12.5 and adult ISC. Note 
the exon represented with the solid box at the bottom. ISH specific for the gene Shh in fixed sections of 
mouse embryos e12.5 (B), e14.5 (C), e15.5 (D) and adult mouse small intestine (E). Note the different 
structures present in the sections throughout the developmental stages, l – lumen, e - endothelium, m – 
mesenchyme, iv – intravillus, v – villi, c – crypt. Scale bar corresponds to 50m to all sections except E, 
where it corresponds to 75m. 
 
According to the RNA-seq data, the expression of Shh in the ISC of the mouse embryo, 
e12.5, and in the adult small intestine, is higher at early developmental stages (Fig 4.15 
A). This is confirmed by the ISH analysis of this gene (Fig 4.15 B to E). In the images 
from the ISH it can be observed a stronger staining in the intestinal endothelium at the 
embryonic stages, e12.5, e14.5 and 15.5, analyzed (Fig 4.15 B to D). In the section from 
the adult small intestine (Fig 4.15 E) it is not possible to identify a region, in the crypts, 
where the staining is stronger, even though the background is slightly strong. 
The probe for the gene Ngn3 was prepared and the ISH performed. Nevertheless, no 
specific signal was produced during the ISH of slides targeting this gene transcripts. For 
this reason, no results were presented. 
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4.3 Isolation of Intestinal cells 
 
The isolation of the target cell populations, ISC and AE, required upstream steps prior 
to cell sorting. To successfully isolate the embryonic ISC, independently of the 
embryonic stage, the small intestine was dissected out and  isolated from the embryos 
(Fig 4.16 A and B) . For the isolation of adult ISC and AE population, the small 
intestine was collected from male Lgr5-EGFP-ires-creERT2 and sectioned (Fig 4.16 C), 
prior to further processing. 
 
 
Fig 4. 16: Mouse embryos abdominal organs at developmental stages e12.5 (A) and e14.5 (B) and small 
section of adult small intestine (C). The abdominal organs collected included liver (L), stomach (st), small 
intestine (si), large intestine (li), lungs (lg), heart (h) and in the tissues collected from e12.5 (A) it’s 
possible to identify the ceccum (c). Scale bars are 1 mm for insert A and 2 mm for inserts B and C. 
 
 
4.3.1 Isolation of adult ISCs and AE 
 
The isolation of adult ISCs and AE were carried out in male Lgr5-EGFP-ires-creERT2. 
This mouse strain has the characteristic of expressing EGFP in the cells expressing 
Lgr5 – ISCs. 
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 In order to ensure the purity of the isolated cells, they were stained with EpCAM, 
CD31 and C45 antibodies. This antibody combination allowed the identification of 
dendritic and other immune cells are abundant in the cell suspentions. Cells that were 
co-stained by these three antobodies were rejected in order to obtain clean preparations 
of adult ISCs and AE . Cells that were GFP and EpCAM positive, with a high 
expression of this protein were collected as the ISCs of interest (Fig 4. 17). On the other 
hand, cells only stained with EpCAM corresponded to the targeted AE (Fig 4.18). 
Cells were also stained with DAPI to descriminate between the living and dead cells. 
 
 
Fig 4. 17: Cell sorting (FACS) of adult ISCs from male Lgr5-EGFP-ires-creERT2 stained with EpCAM, 
CD31 and CD45, and DAPI. Cellular events (A), single cell events (B) and Lgr5-eGFP positive events (C) 
were isolated in order to prepare a purified cell suspention of the targeted adult ISCs. 
 
From the cell suspension loaded into the FACS equipment, cells that were positive for 
all the antibodies were isolated. Out of this cell suspension, cells were isolated from 
cellular debris resulting from the preparation (Fig 4.17 A). This accounted for 72.1% of 
all events. The isolated material was further screened in order to discard events that 
were not single cell (Fig 4.17 B). From the all the cellular events, 97.2% were single 
events. Of these, the cells that expressed the Lgr5-eGFP reporter and were alive were 
isolated (Fig 4.17C), accounting for 4.62% of cells 
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Fig 4. 18: Cell sorting (FACS) of adult enterocytes from male Lgr5-EGFP-ires-creERT2 stained with 
EpCAM, CD31 and CD45, and DAPI. Cellular events (A), single cell events (B) EpCAM, CD31 and 
CD45 stained cells (C). Living cells EpCAM positive and CD31/CD45 negative (D) were isolated in 
order to prepare a purified cell suspention of the targeted adult ISCs. 
 
The enterocyte cell suspension was loaded into the FACS equipment and 70.8% were 
celular events (Fig 4.18 A) to be collected out of the cellular debries and other 
contaminants. Single cell events accounted for 97.8% (Fig 4.18 B) of the cellular events 
present in the cell suspension. Cells positive for EpCAM but negative either for CD31 
and CD45 were 45.2% of all single cell events (Fig 4.18 C) and 78.2% of them were 
alive (Fig 4.18 D) and thus collected for further applications. 
 
4.3.2 Isolation of embryonic ISCs 
 
The small intestines that were dissected from the embryos and pooled – 8 to 10 guts 
from each litter. To ensure the purity of the isolated cells, these were stained with the 
antibodies EpCAM and CD31 for the stage e12.5 and with EpCAM, CD31 and CD45 
for the stage e14.5. 
The isolation of the ISCs from stage e12.5 was carried out by collecting the cells that 
were EpCAM positive and CD31 negative (Fig 4.19). At this stage, e12.5, the EpCAM 
will stain the well characterized pan-endodermal surface marker. In order to 
complement the staining and increase the purity of the cells collected, they were also 
stained with CD31. In respect to the isolation of the ISCs at stage e14.5, this was 
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performed in such way that cells co-stained with CD31, CD45 and EpCAM were 
dismissed. Only cells stained with EpCAM were collected for further use (Fig 4.20). 
Staining with DAPI was also performed to identify living cells, with no DAPI staining 
from the dead, stained with DAPI in the nucleus. 
 
 
Fig 4. 19: Cell sorting (FACS) of embryonic endothelium cells from small intestine of stage e12.5, 
stained with EpCAM and CD31. Target cells were EpCAM+/CD31-. Cellular events (A), single cell 
events (B) EpCAM, and CD31 stained cells (C). Living cells EpCAM positive and CD31 negative (D) 
were isolated in order to prepare a purified cell suspention of the targeted embryonic ISCs. 
 
From the FACS sorting, in the cell suspension loaded into the equipment, cells were 
isolated from the cellular debries produced during the preparation, wich accounted for 
79.5% of all events (Fig 4.19 A). The suspension was further screened to discard the 
events that were not single cell collecting 90.3% of all the events (Fig 4.19 B). Out of 
these, cells EpCAM positive and CD31 negative accounted 6.66% (Fig 4.19 C), with 
97.4% of them being alive (Fig 4.19 D). 
 
 
Fig 4. 20: Cell sorting (FACS) of embryonic endothelium cells from small intestine of stage e14.5, 
stained with EpCAM, CD31 and CD45. Target cells were EpCAM+/CD31CD45-. Cellular events (A), 
single cell events (B) EpCAM, CD31 and CD45 stained cells (C). Living cells EpCAM positive and 
CD31/CD45 negative (D) were isolated in order to prepare a purified cell suspention of the targeted 
embryonic ISCs. 
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The cell suspension loaded into the FACS equipment allowed the recovery of 78.1% of 
cellular events out of the cell debries and other contaminants (Fig 4.20 A). Single cell 
events accounted for 94.4%  (Fig 4.20 B) of all cellular events in the suspension. Cells 
positive for EpCAM but negative either for CD31 and CD45were 12.9% of all single 
cell events (Fig 4.20 C) and 96.2% of them were alive (Fig 4.20 D) and thus collected 
for further applications. 
 
4.4 Bisulfite sequencing 
 
In order to proceed for the bisulfite sequencing, cells that were sorted by FACS were 
processed. Genomic DNA was extracted and sonicated and sodium bisulfate convertion 
was carried out.  
Simoultaneously, target genes were selected to be further analysed using information 
from the MDS-seq protocoled that was carried out. Genes to be analyzed were selected 
in accordance to their methylation profile. 
Genes that were selected were Ndufaf3 (Fig 4.21), Id2 (Fig 4.22), Foxa1 (Fig 4.23), 
Nrp2 (Fig 4.24), Shh (Fig 4.25), Fzd2 (Fig 4.26), Meis1 (Fig 4.27), Grb10 (Fig 4.28), 
Mdk (Fig 4.29), Olfm4 (Fig 4.30), Elf3 (Fig 4.31), Ephb3 (Fig 4.32), Vdr (Fig 4.33), 
Oct4 (Fig 4.34), Lgr5 (Fig 4.35) and Efbn2 (Fig 4.36).  
 
The following images are repesentative of each stage and method. Replicates were n=3 
for the different stages at each protocol – RNA and MBD-seq.  
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Fig 4. 21: Expression (lines A and B) and methylation (lines C and D) profiles of a region of the gene 
Ndufaf3 in ISC at developmental stage e12.5 (lines A and C) and adult (lines B and D). Note the exon 
represented with the solid blue boxes at the bottom. 
 
Expression and methylation patterns of the gene Ndufaf3 (Fig 4.21), resulting from 
RNA-seq and MBD-seq. This data show a small increase of mRNA (Fig 4.21 A and B) 
in the adult ISC (Fig 4.21 B), when compared to the same cells from stage e12.5 (Fig 
4.21 A). These changes were not observed in the methylation of the gene (Fig 4.21 C 
and D). 
 
 
Fig 4. 22: Expression (lines A and B) and methylation (lines C and D) profiles throughout the gene Id2 in 
ISC at developmental stage e12.5 (lines A and C) and adult (lines B and D). Note the exon represented 
with the solid blue boxes at the bottom. 
 
Analyzing the data from RNA-seq regarding the gene Id2 (Fig 4.22 A and B), it can be 
noticed that the expression of this gene is higher in the embryo, at stage e12.5 then it is 
in the adult ISC. Nevertheless, no changes in the methylation pattern (Fig 4.22 C and D) 
can be detected between the different developmental stages.  
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Fig 4. 23: Expression (lines A and B) and methylation (lines C and D) profiles of a region of the gene 
Foxa1 in ISC at developmental stage e12.5 (lines A and C) and adult (lines B and D). Note the exon 
represented with the solid box at the bottom. 
 
 
Focusing in the RNA-seq and MBD-seq data for the gene Foxa1 (Fig 4.23) it can be 
noticed differences in the expression profile of this gene (Fig 4.23 A and B). Regarding 
this data, a higher expression of Foxa1 is observed from the ISC at stage e12.5 (Fig 4.23 
A). On the other hand, the expression decreases in the analysis of the adult ISC (Fig 
4.23 B). Concerning the methylation (Fig 4.23 C and D), data shows that there is no 
methylation in either stages. 
 
 
Fig 4. 24: Expression (lines A and B) and methylation (lines C and D) profiles of a region of the gene 
Nrp2 in ISC at developmental stage e12.5 (lines A and C) and adult (lines B and D). 
 
Data from RNA-seq and MBD-seq on Nrp2 (Fig 4.24) indicates that the expression of 
this gene in low for the stage e12.5 (Fig 4.24 A) and lower or inexistent in the adult ISC 
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(Fig 4.24 B), that may be due to the fact that the represented region corresponds to an 
intron. In respect to the methylation pattern (Fig 4.24 C and D), this is much higher in 
the adult ISC (Fig 4.24 D) and very low in at e12.5 (Fig 4.24 C). 
 
 
Fig 4. 25: Expression (lines A and B) and methylation (lines C and D) profiles of a region of the gene Shh 
in ISC at developmental stage e12.5 (lines A and C) and adult (lines B and D). Note the exon represented 
with the solid box at the bottom. 
 
Data from RNA-seq and MBD-seq for the gene Shh (Fig 4.25) gives a representation of 
the expression and methylation patterns. Regarding the expression pattern, transcripts 
are higher in the ISC at e12.5 (Fig 4.25 A) specially over the exon (bottom solid box, 
Fig 4.25) and inexistent in the adult ISCs (Fig 4.25 B). This gene present a high 
methylation in the adult ISCs (Fig 4.25 D) in the exon and also in the surrounding 
regions. In the e12.5 ISCs, methylation is very low (Fig 4.25 C). 
 
 
Fig 4. 26: Expression (lines A and B) and methylation (lines C and D) profiles of a region of the gene 
Fzd2 in ISC at developmental stage e12.5 (lines A and C) and adult (lines B and D). Note the exons as 
solid boxes at the bottom of the image. 
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Observing the RNA-seq and MBD-seq data regarding the gene Fzd2 (Fig 4.26) it can be 
noticed a higher expression of the gene at e12.5 (Fig 4.26 A) and a very low or 
inexistent methylation for the same stage (Fig 4.26 C). For the adult ISC, the opposite 
can be observed – low amount of transcripts (Fig 4.26 B) and highly methylated regions 
(Fig 4.26 D). 
 
 
Fig 4. 27: Expression (lines A and B) and methylation (lines C and D) profiles of a region of the gene 
Meis1 in ISC at developmental stage e12.5 (lines A and C) and adult (lines B and D). Note the exons as 
solid boxes at the bottom of the image. 
 
Focusing in the RNA-seq and MBD-seq data for the gene Meis1 (Fig 4.27) it can be 
noticed an expression at stage e12.5 (Fig 4.27 A) although low, that is not present in the 
adult ISCs (Fig 4.27 B). Regarding methylation, this is higher in the adult cells (Fig 
4.27 D), where no expression was detected, while being very low in the e12.5. stage 
(Fig 4.27 C). 
 
 
Fig 4. 28: Expression (lines A and B) and methylation (lines C and D) profiles of a region of the gene 
Grb10 in ISC at developmental stage e12.5 (lines A and C) and adult (lines B and D). 
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Data from RNA and MBD-seq concerning Grb10 (Fig 4.28) show expression of the 
gene only on the embryonic stage, e12.5 (Fig 4.28 A), as no transcripts were detected in 
the adult ISC (Fig 4.28 B). Nevertheless, it is important to mention that the region of the 
gene being portrayed reefers to an intron. In respect to the methylation of the gene 
Grb10, it is possible to observe that this is higher in the adult ISC (Fig 4.28 D). 
Nonetheless, methylation was detected in the DNA from cells at e12.5 (Fig 4.28 C) 
although at low levels.  
 
 
Fig 4. 29: Expression (lines A and B) and methylation (lines C and D) profiles of a region of the gene 
Mdk in ISC at developmental stage e12.5 (lines A and C) and adult (lines B and D). Note the exons as 
solid boxes at the bottom of the image. 
 
Expression and methylation pattern on the gene Mdk show differences between the two 
developmental stages analyzed (Fig 4.29). Regarding gene expression, RNA-seq data 
show that Grb10 is present in the e12.5 stage (Fig 4.29 A) and with a higher number of 
transcripts corresponding to the gene’s exons. In the adult ISCs, no transcripts were 
detected (Fig 4.29 B). In respect to the MBD-data, no methylation was detected in the 
embryonic stage (Fig 4.29 C) while the gene was methylated in the adult ISCs in the 
introns and exons alike (Fig 4.29 D). 
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Fig 4. 30: Expression (lines A and B) and methylation (lines C and D) profiles throughout the gene 
Olfm4 in ISC at developmental stage e12.5 (lines A and C) and adult (lines B and D). Note the exons as 
solid boxes at the bottom of the image. 
 
 
Analyzing the expression and methylation data for the gene Olfm4 (Fig 4.30) 
differences can be noted between the two developmental stages studied. In respect to the 
expression profile of Olfm4 (Fig 4.30 A and B), it can be noticed that this gene is 
expressed in the adult ISCs (Fig 4.30 B) while being inexistent in the embryonic ISCs at 
stage e12.5 (Fig 4.30 A). Regarding the methylation (Fig 4.30 C and D), the opposite 
can be observed. Methylation in the embryonic stage (Fig 4.30 C) and reduced in the 
adult cells (Fig 4.30 D). 
 
 
Fig 4. 31: Expression (lines A and B) and methylation (lines C and D) profiles of a region of the gene 
Elf3 in ISC at developmental stage e12.5 (lines A and C) and adult (lines B and D). Note the exons as 
solid boxes at the bottom of the image. 
 
Focusing on the data for the gene Elf3 from RNA and MBD-seq (Fig 4.31) changes in 
expression and methylation can be observed between the stages studied. The gene Elf3 
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has a higher expression in the adult ISCs (Fig 4.31 B). Although this gene also appears 
to be expressed in the embryonic ISCs at e12.5 (Fig 4.31 A), transcript levels are low. 
On the other hand, DNA from e12.5 is highly methylated (Fig 4.31 C), while no 
methylation is detected in the adult ISCs (Fig 4.31 D). 
 
 
Fig 4. 32: Expression (lines A and B) and methylation (lines C and D) profiles of a region of the gene 
Ephb3 in ISC at developmental stage e12.5 (lines A and C) and adult (lines B and D). Note the exons as 
solid boxes at the bottom of the image. 
 
In respect to the gene Ephb3, RNA and MBD-seq data (Fig 4.32) show that there are 
differences between the two stages analyzed. Based in RNA-seq Ephb3 was showed to 
be expressed in the adult ISCs (Fig 4.32 B) and to be expressed at lower levels in stage 
e12.5 (Fig 4.32 A). MBD-seq data indicate a strong methylation of DNA in the 
embryonic ISCs (Fig 4.32 C) while being absent in the adult ISCs (Fig 4.32 D). 
 
 
Fig 4. 33: Expression (lines A and B) and methylation (lines C and D) profiles of a region (an intron) of 
the gene Vdr in ISC at developmental stage e12.5 (lines A and C) and adult (lines B and D). 
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Analyzing the RNA-seq data related to the expression of Vdr (Fig 4.33 A and B) it can 
be noticed a higher amount of transcripts in the adult ISCs (Fig 4.33 B) while none were 
detected in the samples from e12.5 (Fig 4.33 A). Data regarding DNA methylation also 
show differences among the different stages (Fig 4.33 C and D). MBD-seq data show a 
higher methylation on the DNA from stage e12.5 (Fig 4.33 C). It also shows that some 
methylation in the adult ISCs have occurred (Fig 4.33 D), although lower than the 
detected for the embryonic ISCs. 
 
 
Fig 4. 34: Expression (lines A and B) and methylation (lines C and D) profiles of a region (an intron) of 
the gene Oct4 in ISC at developmental stage e12.5 (lines A and C) and adult (lines B and D). 
In respect to the gene Oct4, the RNA-seq protocol did not detect any transcripts present 
neither at stage e12.5 (Fig 4.34 A) neither in the adult ISCs (Fig 4.34 B). Nevertheless, 
the absence of transcripts in the region of the gene present in Fig 4.34 can be due to the 
fact that the region presented is an intron of the gene. Oct4 methylation is present in 
both stages (Fig 4.34 C and D). 
 
 
Fig 4. 35: Expression (lines A and B) and methylation (lines C and D) profiles of a region of the gene 
Lgr5 in ISC at developmental stage e12.5 (lines A and C) and adult (lines B and D). Note the exons as 
solid boxes at the bottom of the image. 
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Expression and methylation pattern on the gene Lgr5 show that while differences 
between the ISCs of the two developmental stages analyzed – e12.5 and adult (Fig 4.35) 
are present, the same is not noticed in the methylation. From the RNA-seq, it can be 
noticed a higher expression of the gene in the adult ISCs (Fig 4.35 B), specially in the 
regions corresponding to the exons. A very low amount of transcripts can be detected in 
the data from the e12.5 ISCs (Fig 4.35 A). In respect to the methylation of the gDNA 
coding for Lgr5, small differences could be noted by comparing the embryonic and 
adult ISCs (Fig 4.35 C and D). 
 
 
Fig 4. 36: Expression (lines A and B) and methylation (lines C and D) profiles of a region of the gene 
Efbn2 in ISC at developmental stage e12.5 (lines A and C) and adult (lines B and D). Note the exons as 
solid boxes at the bottom of the image. 
 
Analysis of RNA and MBD-seq data regarding the gene Efbn2 (Fig 4.36) while 
indicating differences in transcript levels in the ISCs at e12.5 and adult – with 
expression at e12.5 (Fig 4.36 A) – show no major differences in the methylation pattern 
of DNA (Fig 4.36 C and D), being high in both stages. 
Based on the MBD-seq data previously presented – Fig 4.21 to Fig 4.36, primers for the 
Bisulfite-seq were designed to amplify fragments that were unmethylated in both stages, 
methylated in adult and unmethylated in embryo, methylated in embryo and 
unmethylated in adult and methylated in both stages. This study was complemented 
with methylation analysis of DNA from ISC from stage e14.5 and from adult 
enterocytes.  
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Samples were treated with the sodium bisulfate followed by PCR in order to amplify the 
fragment of interest. Primer optimization was also taken as an opportunity to screen the 
primers that allowed fragment amplification. Products of the successful PCR reactions 
were loaded into an agarose gel (Fig 4.37). 
 
  
Fig 4. 37: Products of PCR reactions in a 1.5% agarose gel in 1X TAE stained with EtBr. PCR reaction 
was carried out for the amplification of several gene fragments – Ephb3, Id2, Fzd2, Oct4, Ndufaf3, Olfm4, 
Elf3 and Grb10 – after sodium bisulfate treatment of DNA. Triplicates of each developmental stage 
(e12.5, e14.5, adult ISC and AE) were prepared.  
 
From the initial 16 genes selected, 8 were successfully amplified by PCR and the 
fragments obtained had sizes corresponding to the prediction when primers design 
(Table 3.10). PCR products were obtained for all samples, although band intensity could 
vary slightly. 
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The PCR fragments were to be quantified and pooled for each of the samples in order to 
proceed to sequencing. In parallel experiments that were being carried out in the group, 
it was detected an increase on available DNA in the samples being used for the bisulfate 
sequencing when compared with the samples used for the MBD-seq (data not shown). 
For this discrepancy, the fragments prepared for the bisulfate sequencing were not 
sequenced, as the results would not be comparable.  
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5. Discussion 
 
Stem cells are able to self-renew and to specialize in multiple differentiated cell types
62
. 
These differentiated cells are what will give an organism the ability to respond to the 
diverse environmental, developmental and/or metabolic cues
69
. The process through 
which these highly specialized cells arise, begin at the stem cells and as they undergo 
crucial changes in gene expression, they differentiate and acquire their final identity.
62
 
However, it is important to keep in mind that although the transcripts present in a fully 
differentiated cell are highly specific, all cells in an organism share the same DNA 
between each other, even though they are located in different tissue or found at different 
developmental stages
69,76
. The mechanisms involved in the acquisition of such a tight 
expression program is the result of epigenetic modification to the DNA
62
. Results in the 
present thesis show that different developmental stages have different genetic programs 
being expressed and also, that, for the most cases, the modifications in the epigenetic 
marker DNA methylation are associated with the expression state of the gene the 
marker is associated with.  
 
The main signaling pathways regulating the maintenance of the stem cells in the small 
intestine include Wnt/-catenin, Notch, BMP and Hh. These signaling cascades have 
their own role in maintaining the cell niche. In the small intestine, Wnt/-catenin is 
required for ISC maintenance and proliferation as well as for crypt 
compartmentalization and epithelium differentiation through a Wnt gradient that is 
established along the crypt-villus axis
4,5,27,34
. Notch, on the other hand, signals for the 
maintenance of the stem cell signal (suppressing cell fate decisions), cellular patterning 
and cell organization
4,36-38
. In the small intestine Notch pathway controls the 
differentiation of daughter cells into enterocytes while, together with Wnt, promotes 
ISC proliferation
3,39,40
. In respect to the BMP and Hh pathways, the first inhibits stem 
cell proliferation while the second is key for the normal embryonic development of the 
gut and its presence in the adult gut is related to stem cell maintenance, proliferation and 
differentiation
27,48,49
. 
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Analysis of the RNA-seq data allowed the selection of set of genes potentially involved 
either in the development of the small intestine in embryos or the maintenance of the 
ISCs in the adult small intestine. An expression analysis was performed in this study by 
ISH and to detect the transcripts of Ascl2, Notch2, Hes1, Shh, Btg2, Cps1, Dusp1, 
Kcne3, Muc4 and Igfbp5.  
The genes selected for ISH were among the many that, through RNA-seq analysis, 
presented different expression states in the stages analyzed. In fact, the adult ISCshowed 
transcription of several of the genes selected. The genes identified in the adult cells 
were Ascl2, Notch2, Hes1, Btg2, Cps1, Dusp1, Kcne3 and Muc4. It was interesting to 
note that from these genes only Ascl2, Notch2 and Hes1 were part of the major 
signaling pathways, with Ascl2 being a part of Wnt pathway and Notch2 and Hes1 
being a part of Notch pathway
4,37,38,77
. In respect to the remaining genes, which were 
expected to be involved processes such as cell growth and/or proliferation, they were 
not directly associated with a pathway with the exception of Dusp1 which is involved in 
the MAPK pathway, thus showing that although Notch, Wnt and the other major 
signaling pathways are relevant for the ISC maintenance and differentiation, they are 
not the only pathways involved.  
Signal from the ISH associated with the transcripts of Ascl2, Btg2, Cps1, and Muc4 was 
only detected in the adult ISCs (Fig 4.6, 4.7, 4.8 and 4.13, respectively), while 
transcripts were detected throughout all the embryonic stages analyzed (e12.5, e13.5, 
e14.4 and e15.5) and adult in the ISH targeting Dusp1, Kcne3, Notch2 and Hes1. This 
distribution of the transcripts can be associated with the functions of each of the genes. 
The first group, Ascl2, Btg2, Cps1 and Muc4, include a gene belonging to the 
Wnt/-catenin pathway (Ascl2), genes implicated in cell cycle arrest (Btg2)78, another 
gene who unique activity is ammonia metabolization (Cps1)
79,80
 and Muc4, an epithelial 
mucin that can also regulate epithelial renewal and differentiation
81
. All of these genes 
(with the exception of Cps1) have a role in the maintenance of cells found in the adult 
stem cell niche. Nevertheless, in a previous work from van Beers et al(1998) Cps1 
transcripts were detected in the crypts of adult rat small intestine
79
 which is in 
accordance with observations from the present study. In the second set of genes are 
Notch2 and Hes1 components of the Notch pathway and Dusp1 that is involved in the 
control of genes promoting cell proliferation and differentiation
82,83
. The exception in 
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this group is Kcne3, a subunit of a potassium chanel
84
 with no data found associating 
this gene with stem cell maintenance and/or differentiation. 
Signal in the ISH targeting the genes Igfbp5 and Shh was not detected in adult ISCs 
(Fig 4.11 and 4.15) but instead in the embryonic stages. The results in this study 
regarding Shh are in accordance with the expected as it has been described that Shh is 
expressed throughout the embryonic epithelium, becoming progressively restricted into 
the proliferative regions of the small intestine
13,54
. In respect to the Igfbp5, this gene is 
also involved in the development of the small intestine by regulating the IGF and 
consequently cellular growth and differentiation
85,86
 
With the ISH it was possible to validate RNA-seq data while allowing to better 
understanding of how these genes integrate the gene programs leading to gut 
development (in embryo) and the maintenance of the small intestine. It was not 
surprising the fact that the majority of the genes analyzed had a role in cell maintenance, 
proliferation or differentiation, despite belonging or not to one of the major signaling 
pathways. What was interesting was to have detected, in this study, the genes Cps1 and 
Kcne3 being detected in these cell populations when no information so far has related 
these genes with the processes that occur in this cells. 
  
 
RNA-seq data and ISH results have showed that gene expression changes through the 
development of the small intestine. Genes that are transcribed at one moment may not 
be in the other. One of such cases is the gene programs in the embryonic development.  
During embryogenesis cells begin as totipotent cells with the potential do differentiate 
in any type of cell. Progressively cells undergo changes in gene expression, which, in 
turn, causes for several factors to be progressively silenced
62
. This silencing result in a 
more specific cell type. Such cell type can be an adult stem cell that although able to 
divide and multiply is already committed to a lineage, or a fully differentiated cell – not 
able to divide or multiply, but fully adapted to the tissue and able to respond to different 
environmental, developmental and metabolic cues
62,69
. The selective expression at this 
moment, with the silencing of some factors and activation of others, is not the result of 
changes in DNA sequence but are a consequence of heritable epigenetic rearrangements 
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of DNA
62,64
. As epigenetic reinforce the decisions regarding cell-fate that were taken, 
they also create a barrier against a setback towards preceding cell states
87
. 
Epigenetic changes include DNA methylation, chromatin remodeling and histone 
modifications, to name a few
63-65,87,88
. From the different epigenetic marks, the work 
developed in this thesis focused in DNA methylation. 
Results from MBD-seq allowed to collect data regarding the epigenetic status of DNA, 
focused on DNA methylation, in the ISCs isolated from embryos at stage e12.5 and 
adult small intestine. Some genes were selected for further scrutiny by bisulfite 
sequencing. Those genes were Shh, Grb10, Foxa1, Id2, Ndufaf3, Nrp2, Fzd2, Meis1, 
Mdk, Efbn2, Lgr5, Vdr, Olfm4, Elf3, Ephb3 and Oct4.  
As expected since the cell populations focused in this study were stem cells from the 
small intestine. Selection of these genes were based in 1) the stage they were 
expressed – e12.5 and/or adult – using the data from RNA-seq and 2) the methylation 
status of each gene in the different stages, which was determined by MBD-seq data 
analysis (Fig 4.21 to Fig 4.36).  
In general, the genes expressed in the embryonic (e12.5) ISC – Shh, Grb10, Foxa1, Id2, 
Ndufaf3, Nrp, Fzd2, Meis1, Mdk and Efnb2 – were unmethylated at this stage. The 
exception was Efbn2 that although methylated and expressed at this stage. It is also to 
be noted that there were genes (Efbn2) that maintained their unmethylated status 
although inactive in the adult ISCs. In respect to the genes expressed in the adult ISC – 
Lgr5, Vdr, Olfm4, Elf3 and Ephb3 – there was also a gene that although methylated, 
was expressed at this stage, Lgr5. Also among the genes expressed in the adult ISCs, 
there were some, Ndufaf3, Id2 and Foxa1,that were unmethylated at e12.5. 
Through this work, it was possible to verify that DNA methylation has an important role 
in the regulation of gene expression in ISCs – the majority of genes were methylated 
when they were not expressed. This results are in accordance with what has been 
described since methylation is the more recurrent epigenetic modification in 
eukaryotes
88
. As this marks are present in gDNA, they inhibit transcription initiation by 
blocking the bind of transcription factors to DNA or by recruiting methyl-binding 
proteins (MBPs) changing the chromatin environment
88,89
. As the major changes in this 
patterns occur at periods of genome reprogramming – primordial germ cells and 
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preimplantation embryos – when marks are erased and reset76, the results from e12.5 
confirm the presence of methylation marks controlling cell differentiation towards a 
fully functioning organism. However, modifications on methylation detected between 
the ISCs at e12.5 and in adult is also in accordance with what has been described, that 
states that methylation can change as a response to genetic variation and environmental 
cues, among other factors
90
.  
For the majority of the genes analyzed in this study, expression changed between the 
different developmental stages. It was possible to establish a relation to their 
methylation pattern – genes that were being transcribed weren’t methylated. However 
there were genes with a methylation profile that did not changealthough their 
transcription did. In this cases, it can be hypothesized that other epigenetic marker(s) 
is(are) involved in the regulation of gene transcription. One of the possible epigenetic 
markers which may be involved in the regulation of these genes is histone modifications. 
The role of histone modifications in gene transcription is a result of modifications that 
occur on specific residues such as methylations, phosphorylations, acetylations, 
sumoylations and ubiquitinations
69,91
. These histone modifications will have an impact 
in the nucleosome, and consequently alters chromatin condition, thus influencing 
transcriptional status of genes
69,92
. One of these cases has been described for the genes 
found in highly packed areas of chromatin. In such cases, the genes and their respective 
promoters are inaccessible and are not able to recruit the RNA polymerase remaining 
silenced
69
. The opposite has been reported in embryonic stem cells where chromatin is 
“open” due to a global high level of histone acetylation which maintains cells 
undifferentiated and pluripotent state
91,93
.   
 
5.1  Future perspectives: 
 
Data presented in this study shows that different genes are required for stem cell from 
small intestine to maintain themselves or to differentiate. ISH also give strong 
indications that changes occur in a dynamic manner throughout development until 
maturity is reached. Analysis of epigenetic markers on a few selected genes, has 
provided data that relate gene transcription with DNA methylation where increase in 
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cytosine methylation was associated with a state of active transcription. From the 16 
genes analyzed some did not present this relation. 
Approaches that would enrich this study include: 
- RNA-seq of ISC from intermediate embryonic stages, such as e14.5, and also 
from newborn mice in order to understand the moments when the genetic programs 
change; RNA-seq on adult enterocytes and transit amplifying cell may allow the 
comprehension of the signaling pathways involved in cell specification; 
- MBD-seq on ISCs from e14.5, newborn, adult enterocytes and transit 
amplifying cells aiming to explain how this epigenetic markers change during 
development and cell specification; 
- ChIP-seq on ISCs from embryos (e12.5 and e14.5) and adult small intestine as 
well as in adult enterocytes and transit amplifying cells. This, together with the 
MBD-seq data will enrich the information of the epigenetic control associated with gene 
transcription. 
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6. Conclusion 
 
This study, focused in the intestinal stem cells, show that maintenance of stem cells in 
their niche is associated with specific gene programs. The signaling pathways that are 
active in these cells allow for the maintenance of stem cell population and give the cues 
for cell differentiation into tissue specific cells. However, these pathways are not 
present through all the developmental stages. Results present in this report indicate that 
during embryonic development gene programs are activated or deactivated. 
In order to understand how genes were “turned on or off” without changes in DNA 
sequence, MBD-seq data showed that gene transcription is associated with changes in 
epigenetic markers. In this study DNA methylation profile was analyzed allowing the 
establishment of a relation according to which, the majority of the genes being 
transcribed are unmethylated, changing to a methylated state when the genes are 
deactivated. However, it was also possible to hypothesize that DNA methylation was 
not the only epigenetic marker present in these cells. 
In face of these results it can be concluded that intestinal stem cells are maintained 
through several well known and specific pathways present from early developmental 
stages that modify as the genetic program narrows and also that this genetic program is 
under the control of epigenetic markers of great importance for ISC specification. 
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Annex 1: Solutions 
PBS 
For 1 L of PBS 10X, the following salts were weighted 
80 g NaCl 
2g KCl 
14.4g Na2HPO4 
2.4g  KH2PO4 
 
Water was added until a final volume of 1 L and the solution was autoclaved 
 
Tris-HCl 
To prepare 1 L of Tris-HCl 1 M, pH 7.5 
121.14 g of Tris were weighted and water was added to dissolve the salt. pH was 
adjusted with HCl and water added to the final volume. 
 
Hybridization buffer 
To prepare 50 ml of Hybridization Buffer the following solutions were mixed 
12.5 ml SSC 20X 
25 ml Formamide 100 
5 ml  Dextrane Sulfate 50% 
1 ml Denhart 50X 
500 l tRNA 10 mg/ml 
100 l Heparin 50 mg/ml 
500 l EDTA 0.5M 
 
pH was adjusted to 4.5 – 5.0 with Citric Acid  
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SSC, pH 4.5 - 5.0 
To prepare 1 L of SSC 20X, the following salts were added  
175.3 g NaCl 
88.2 g NaCitrate 
Water was added until half the volume, pH was adjusted with Citric Acid and water 
was added for the final volume of 1 L. 
 
Blocking solution 
Add Boehring Blocking Reagent 10% for a final concentration of 1% and goat 
serum for a final concentration of 10%. 
Finalize the volume with TBSX 
 
TBSX 
To prepare 1 L of TBSX, the following solutions were mixed 
2 ml KCl 1M 
30 ml NaCl 1M 
100 ml Tris-HCl 1 M pH 7.5 
1 ml  Triton X-100 10 % 
 
Water was added for the final volume of 1L. 
 
NTMT 
To prepare 500 ml of NTMT, the following solutions were mixed: 
25 ml MgCl2 
10 ml NaCl 1M 
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100 ml Tris-HCl 1 M pH 9.0 
500 l Tween-20 
 
Water was added until the final volume 
 
Staining solution 
To the final volume of NTMT (for a final volume of 700 l per slide), 1 l/ml of 
NBT and 3.5 1 l/ml of BCIP were added. 
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Annex 2 : pGEM cloning vector map and reference points  
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Annex 3 : Preparation of competent cells 
To obtain competent bacteria cells, one colony of the strain Escherichia coli XL-1 Blue, 
was isolated from a plate of LB medium (30 mg/ml tetracycline) and used to inoculate 5 
ml of LB medium. Cells were incubated for 12-16 h at 30ºC and 250 rpm. 
 1 ml of the culture was inoculated in 250 ml of SOB medium and incubated 
with agitation at 18ºC until a DO of 0.6 nm was reached. The bacterial suspension was 
incubated on ice to stop growth for 10 min and transferred to 50 ml Falcon tubes and 
centrifuged 1200 g, 10 min, 4ºC. The supernatant was discarded and the pellet 
ressuspended in 16 ml of cold transformation buffer (TB), a rich solution of CaCl2, 
incubated on ice for additional 10 min and centrifuged as described above. DMSO 
(cryo-preserving agent) was added until a final concentration of 7% was reached and 
bacteria were incubated for 10 min and aliquoted in 100 µl samples and immediately 
frozen in liquid nitrogen and stored at -80ºC until further use. 
 
SOB médium (250 mL): 
2% Bacto tryptone (5g); 
1.5% yeast extract (1.25g); 
10 mM NaCl (500 L stock 5M); 
2,5 mM KCl (625 L stock 1M); 
10 mM MgCl2 (2.5 mL stock 1M); 
10 mM MgSO4 (2.5 mL stock 1M); 
Autoclave after prepare. 
 
TB buffer (100 mL): 
10 mM Pipes (0.30 g); 
15 mM CaCl2 (1.5 mL stock 1M); 
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250 mM KCl (25 mL stock 1M); 
Adjust pH to 6.7 with KOH 1M, other wise the pipes will not dissolve (take in 
consideration that the pH changes very fast when near the optimum). After is fully 
dissolved and the pH is at 6.7 add 55mM MnCl2 (0.69 g). Filter with 0.22 m filter 
to sterilize. Do not autoclave the solution. Store it at 4 ºC until use. 
